<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t7s45sccdcp8 st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="ENDOCRINE SYSTEM DISORDERS PROPER-1.pdf">ENDOCRINE SYSTEM DISORDERS PROPER-1.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">4.5MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> ENDOCRINE SYSTEM DISORDERS PROPER-1.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="endocrinology">ENDOCRINOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#endocrinology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>H. Kibicho</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="unit-objectives">Unit Objectives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-objectives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>By the end of the unit the students should be able to describe:</p>
<p>a. Anatomy and physiology of endocrine system
b. Assessment of the endocrine system
c. Describe various endocrine disorders under the headings:</p>
<p>Definition, clinical features, medical, nursing and surgical interventions</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-endocrine-system">THE ENDOCRINE SYSTEM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>“endo” means within.</p>
</li>
<li>
<p>Endocrine system is a system of ductless glands that secrete hormones. The glands are widely separated with no anatomical links.</p>
</li>
<li>
<p>It is a chemical control system.</p>
</li>
<li>
<p>It functions in conjunction with the nervous system to control the internal environment (homeostasis).</p>
</li>
<li>
<p>These glands consist of secretory cells which secrete hormones and dense network of capillaries which carries hormones in blood</p>
</li>
<li>
<p>Glands: specialized tissues that produce a hormone or product.</p>
</li>
<li>
<p>Hormones: chemical messengers produced by ductless/endocrine glands which flow directly into the blood where they are carried to another organ to influence activity, growth and nutrition.</p>
</li>
<li>
<p>Hormones together with the ANS regulate the internal environment.</p>
</li>
<li>
<p>Rapid action by the nervous system is balanced by slower hormonal action...permitting precise control of organ functions in response to varied changes within and outside the body.</p>
</li>
<li>
<p>Endocrine glands</p>
</li>
<li>
<p>Are composed of secretory cells arranged in minute clusters known as acini.</p>
</li>
<li>
<p>Are ductless</p>
</li>
<li>
<p>Have a rich blood supply so that the hormones they produce enter the bloodstream rapidly.</p>
</li>
<li>
<p>Secrete chemicals known as hormones</p>
</li>
<li>
<p>Endocrine glands produce a variety of hormones which drive very different processes.</p>
</li>
<li>
<p>Many glands are controlled by the Hypothalamus and Pituitary glands.</p>
</li>
<li>
<p>Endocrine glands are</p>
</li>
<li>
<p>1 pituitary gland</p>
</li>
<li>
<p>1 thyroid gland</p>
</li>
<li>
<p>4 parathyroid glands</p>
</li>
<li>
<p>2 adrenal/suprarenal glands</p>
</li>
<li>
<p>The pancreatic islets (islets of langerhans)</p>
</li>
<li>
<p>1 pineal gland or body</p>
</li>
<li>
<p>1 thymus gland</p>
</li>
<li>
<p>2 ovaries in the female</p>
</li>
<li>
<p>2 testes in the male</p>
</li>
</ul>
<p>Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-endocrine-system">The Endocrine System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-26a7e106.jpeg" alt="img-0.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assignment">Assignment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assignment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Define the following terms and give examples of each
a) Endocrine glands
b) Exocrine glands
c) Autocrine glands
d) Paracrine glands
e) Juxtacrine glands</p>
</li>
<li>
<p>Define the following terms
a) Hormones
b) Neurohormones
c) Pherohormones
d) Interleukins
e) Interferons</p>
</li>
</ol>
<p>cont</p>
<ul>
<li>The glands are called <strong>ductless</strong> (do not have ducts to carry secretions) because hormones diffuse directly into the blood stream</li>
<li>This differentiate them from exocrine glands eg sweat gland</li>
<li>The major glands are: Pituitary gland, Thyroid gland, Parathyroid gland, Thymus gland, Adrenal gland, Testes and Ovaries</li>
</ul>
<p><img src="assets/images/image-20251224-5fea70e6.jpeg" alt="img-1.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principle-functions-of-endocrine-system">PRINCIPLE FUNCTIONS OF ENDOCRINE SYSTEM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principle-functions-of-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Growth, metabolism, &amp; tissue maturation by growth hormone</li>
<li>Ion regulation by parathyroid hormone</li>
<li>Heart rate &amp; blood pressure regulation</li>
<li>Blood glucose control by glucagon and insulin</li>
<li>Immune system regulation by thyroid hormone</li>
<li>Reproductive functions control by FSH and testosterone</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hormones">HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>They are chemical released from living cells that travels some distance to target tissues to have a biological effect</li>
<li>They are chemical messengers</li>
<li>They are secreted in very small amounts and usually transported in the blood</li>
<li>They act on distant target cells</li>
<li>Target cells have specific receptors</li>
<li>The effects are dependent on the programmed response of the target cells</li>
</ul>
<p>cont</p>
<ul>
<li>When hormones arrive at its target cell, it binds to a specific site, the receptor, where it acts to influence a chemical or metabolic reactions made inside the cell</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanisms-of-hormone-release">MECHANISMS OF HORMONE RELEASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanisms-of-hormone-release" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>(a) Humoral: in response to changing levels of ions or nutrients in the blood
(b) Neural: stimulation by nerves
(c) Hormonal: stimulation received from other hormones</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hormonal-mode-of-action">HORMONAL MODE OF ACTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hormonal-mode-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Hormones can act in two ways:</p>
<ol>
<li>Reversing the action of stimulus: negative feedback mechanism</li>
<li>Amplifying the stimulus; positive feedback mechanism</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-negative-feedback-mechanism">1. NEGATIVE FEEDBACK MECHANISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-negative-feedback-mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Occurs when the action of hormone stops its further release.</li>
<li>The stimulus causes a release of hormone which acts on a target organ or tissue and the resulting action of hormone tend to suppress its further release</li>
</ul>
<p>cont</p>
<ul>
<li>Example of negative feedback mechanism</li>
<li>Rising blood sugar stimulates pancreatic cells to release insulin.</li>
<li>insulin increases uptake of glucose hence lowering blood sugar.</li>
<li>When blood sugar is lowered, the production of insulin stops this leads rising blood sugar (humoral hormonal release)</li>
<li>Hormone released; insulin</li>
</ul>
<p>cont</p>
<ul>
<li>Resulting action of hormone : increase uptake of glucose</li>
<li>As a result of glucose uptake ; insulin release stops.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="positive-feedback-mechanism">POSITIVE FEEDBACK MECHANISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#positive-feedback-mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Occurs when the action of hormone causes additional secretion of the same hormone.</li>
<li>Example: rising levels of Oxytocin stimulates contractions in the uterus.</li>
<li>Contractions in the uterus stimulate receptors in the pelvis which triggers the release of more Oxytocin for more contractions until child birth</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classes-of-hormones">CLASSES OF HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classes-of-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Proteins and polypeptides e.g. hormone secreted by anterior and posterior pituitary gland, parathyroid hormone, insulin and glucagon</li>
<li>Steroids: hormones secreted by adrenal cortex e.g. cortisol, aldosterone, hormones secreted by ovaries e.g. estrogen and progesterone, hormone secreted by testes e.g. testosterone</li>
<li>Amines or amino acids: thyroid hormone, epinephrine and norepinephrine</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="endocrine-glands">ENDOCRINE GLANDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#endocrine-glands" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Hypothalamus
(brain region controlling the pituitary gland)</p>
<p>Thyroid gland
(affects metabolism, among other things)</p>
<p><img src="assets/images/image-20251224-1ce5703a.jpeg" alt="img-2.jpeg"></p>
<p>Pituitary gland
(secretes many different hormones, some of which affect other glands)</p>
<p>Parathyroids
(help regulate the level of calcium in the blood)</p>
<p>Adrenal glands
(inner part, called the medulla, helps trigger the "fight or flight" response)</p>
<p>Pancreas
(regulates the level of sugar in the blood)</p>
<p>Ovary
(secretes female sex hormones)</p>
<p>Testis
(secretes male sex hormones)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="glands-of-endocrine-system">Glands of endocrine system<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glands-of-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>1 Pituitary gland</li>
<li>1 Thyroid gland</li>
<li>4 Parathyroid glands</li>
<li>2 Adrenal (suprarenal) glands</li>
<li>The pancreatic islets (islets of langerhans)</li>
<li>1 Pineal gland or body</li>
<li>1 Thymus gland</li>
<li>2 Ovaries in the female</li>
<li>2 Testes in the male</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-pituitary-gland-and-hypothalamus">1. Pituitary gland and hypothalamus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-pituitary-gland-and-hypothalamus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-30f76087.jpeg" alt="img-3.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pituitary-gland-and-hypothalamus">Pituitary gland and hypothalamus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pituitary-gland-and-hypothalamus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Location: in Sella Turcica of sphenoid bone Attached to Hypothalamus by a stalk called Infundibulum</li>
<li>The pituitary gland and the hypothalamus act as a unit.</li>
<li>The hypothalamus has a direct controlling effect on the pituitary gland and an indirect effect on many others.</li>
<li>A sort of master gland. The real boss is the hypothalamus. It is divided into two;</li>
<li>Anterior lobe – [glandular part] Adenohypophysis</li>
<li>Posterior lobe – [neural part] – Neurohypophysis</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-anterior-pituitary-gland-adenohypophysis">1. Anterior pituitary gland (Adenohypophysis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-anterior-pituitary-gland-adenohypophysis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It produces six (6) hormones. The hormones are;</p>
<p>I. Growth hormone(GH)</p>
<p>II. Thyroid stimulating hormone(TSH)</p>
<p>III. Adrenocorticotropic hormone-- (ACTH)</p>
<p>iv. Prolactin</p>
<p>v. Follicle Stimulating Hormone (FSH)</p>
<p>vi. Luteinizing Hormone.(LH)</p>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-posterior-pituitary-gland-neurohypophysis">2. Posterior pituitary gland (Neurohypophysis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-posterior-pituitary-gland-neurohypophysis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Produces two (2) hormones.</p>
<p>i. Antidiuretic Hormone (ADH) (Vasopressin)</p>
<p>ii. Oxytocin</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hypothalamic-control-of-pituitary-gland-secretions">Hypothalamic control of pituitary gland secretions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypothalamic-control-of-pituitary-gland-secretions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The anterior gland is controlled by hormones released by hypothalamus</li>
<li>These hormones are called hypothalamic releasing and inhibiting hormones</li>
<li>These hormones are released from hypothalamus and conducted to anterior pituitary gland through minute blood vessels called pituitary portal system</li>
</ul>
<p>cont</p>
<ul>
<li>Posterior pituitary gland is controlled by nerve signals that originate from hypothalamus and terminate in posterior pituitary</li>
<li>The release of hormones is triggered by excitation of the gland by nerve impulses</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anterior-pituitary-gland">Anterior pituitary gland<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anterior-pituitary-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There are six hormones secreted by anterior pituitary gland</li>
<li>These hormones play role in control of metabolic functions in the body</li>
<li>The release of anterior pituitary hormone follows stimulation of gland by specific releasing hormone produced by hypothalamus</li>
<li>The whole system is control by feedback mechanism</li>
</ul>
<p>cont</p>
<ul>
<li>The six important hormones are</li>
</ul>
<ol>
<li>Growth hormone</li>
<li>Thyroid stimulating hormone</li>
<li>Adrenocorticotropic hormone (ACTH)</li>
<li>Prolactin</li>
<li>Follicle stimulating hormone (FSH)</li>
<li>Luteinizing Hormone (LH)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-growth-hormone">1. GROWTH HORMONE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-growth-hormone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Is also called somatotropic hormone</li>
<li>It's release stimulated by growth releasing hormone and suppressed by growth hormone releasing inhibiting hormone</li>
<li>It is stimulated by hypoglycemia, deep sleep, fasting, exercise, and anxiety.</li>
<li>Peak release is reached in adolescence</li>
<li>It is inhibited by hyperglycemia, glucocorticoids, dihydrotestosterone,</li>
</ul>
<p>cont</p>
<ul>
<li>Inhibition is by negative feedback mechanism</li>
<li>Major target of the hormone are body cells, bones and skeletal muscle tissues.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="functions-of-growth-hormone">Functions of growth hormone<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#functions-of-growth-hormone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Regulates metabolism-by protein synthesis, use of fats for fuel and conservation of glucose</p>
</li>
<li>
<p>promote growth of bones and muscles</p>
</li>
<li>
<p>Thyroid stimulating Hormone</p>
</li>
</ol>
<ul>
<li>Is also called thyrotropin</li>
<li>Its release is stimulated by thyroid releasing hormone from hypothalamus.</li>
<li>Its target is thyroid gland</li>
<li>Function: it stimulate thyroid gland to release thyroxine (T4) and Tri-iodothyronine (T3)</li>
<li>Secretion is regulated by negative feedback mechanism</li>
<li>When blood levels of thyroid hormones is high, secretion of TSH is reduced</li>
</ul>
<ol start="3">
<li>ADRENOCORTICOTROPIC HORMONE (ACTH)</li>
</ol>
<ul>
<li>Its release is triggered by corticotrophin releasing hormone from the hypothalamus</li>
<li>Function: ACTH stimulates adrenal cortex to secrete glucocorticoid hormones especially cortisol</li>
<li>Secretion is regulated by negative feedback mechanism</li>
<li>Other factors that stimulate secretion include hypoglycemia, exercise and stress</li>
</ul>
<ol start="4">
<li>Prolactin</li>
</ol>
<ul>
<li>Stimulate lactation (milk production) immediately after birth.</li>
<li>Its release is stimulated by Prolactin releasing hormone from hypothalamus and it is lowered by Prolactin inhibiting hormone</li>
<li>After birth, suckling stimulates Prolactin secretion and lactation</li>
</ul>
<ol start="5">
<li>FOLLICLE STIMULATING HORMONE</li>
</ol>
<ul>
<li>Stimulate maturation of ovarian follicles.</li>
<li>Stimulates secretion of estrogen by ovaries</li>
<li>Stimulates production of sperm in testes.</li>
<li>Secreted in puberty</li>
</ul>
<ol start="6">
<li>LUTEINISING HORMONE (LH)</li>
</ol>
<ul>
<li>Necessary for final follicular growth and ovulation</li>
<li>Stimulates secretion of progesterone by corpus luteum and secretion of testosterone in males testis.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="posterior-pituitary-gland">POSTERIOR PITUITARY GLAND<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#posterior-pituitary-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Produces two hormones</p>
<ul>
<li>Oxytocin</li>
<li>Antidiuretic Hormone (ADH)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-oxytocin">1. Oxytocin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-oxytocin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Main targets are breast and uterus.</li>
<li>Are released during childbirth into the uterus to stimulate uterine contractions and stretching of uterine cervix as the baby is expelled.</li>
<li>Its controlled by positive feedback mechanism.</li>
<li>Stimulate glandular cells and ducts of lactating breast to eject milk.</li>
<li>The process of milk ejection also involves positive feedback mechanism.</li>
</ul>
<ol start="2">
<li>Anti-Diuretic Hormone (ADH)</li>
</ol>
<ul>
<li>Also called vasopressin</li>
<li>It stimulates the distal convoluted tubules of the KIDNEYS nephrone to reabsorb more water hence leading to decrease urine output</li>
</ul>
<p><img src="assets/images/image-20251224-d52c03ca.jpeg" alt="img-4.jpeg">
Blood levels exert regulatory influences upon the anterior pituitary gland and the hypothalamus</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="thyroid-gland">Thyroid gland<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thyroid-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Highly vascularised gland located in front of larynx at 5th, 6th, 7th cervical and 1st thoracic vertebrae (C5, C6, C7 and T1 vertebrae)</li>
<li>It's made up of two lobes</li>
<li>Blood is supplied through inferior and superior thyroid arteries.</li>
<li>Venous return is by thyroid veins</li>
<li>There are two parathyroid glands laying at posterior surface of each lobe</li>
</ul>
<p><img src="assets/images/image-20251224-b5a32348.jpeg" alt="img-5.jpeg"></p>
<p>cont</p>
<ul>
<li>It is innervated by recurrent laryngeal nerve</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="thyroid-hormones">THYROID HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thyroid-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>There three major thyroid hormones- thyroxine (T4) Tri-iodothyronine (T3) and calcitonin</li>
<li>T4 and T3 are together called thyroid hormone</li>
<li>Both hormones profoundly increases the rate of metabolism in the body.</li>
<li>Their release into the blood is stimulated by TSH from anterior pituitary gland</li>
<li>They are synthesized as large precursor molecules called thyroglobulin</li>
</ul>
<p>cont</p>
<ul>
<li>
<p>Stress, Malnutrition, Low plasma glucose and Exercises stimulate hypothalamus to release thyroid releasing Hormone (TRH)</p>
</li>
<li>
<p>Once released, the TRH is sent to anterior pituitary gland which stimulate thyroid stimulating hormone (TSH)</p>
</li>
<li>
<p>TSH is sent to Thyroid gland to stimulate production of T3 and T4.</p>
</li>
<li>
<p>Iodine react with tyrosine to form thyroid hormone</p>
</li>
<li>
<p>When supply of iodine is deficient, Excess TSH is secreted and there is proliferation of thyroid gland cells and enlargement of gland (goitre).</p>
</li>
<li>
<p>Thyroxine (T4) is produced in large amounts as compared to T3, i.e. 93% of thyroid hormone is thyroxine and only 7% is T3.</p>
</li>
<li>
<p>T3 is more potent than T4.</p>
</li>
<li>
<p>25% of T4 is converted to T3 by de-iodination of T4 to T3.</p>
</li>
<li>
<p>Hence the hormone delivered to tissues is mainly T3.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="functions-of-thyroid-hormone">Functions of Thyroid hormone<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#functions-of-thyroid-hormone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>They are essential for normal growth and development</li>
<li>They regulate metabolism of carbohydrates, fats and proteins</li>
<li>Increases basal metabolic rate and heat production</li>
<li>Regulate expression of genes in the nucleus by increasing or decreasing synthesis of proteins.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="calcitonin">CALCITONIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#calcitonin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is secreted by <strong>parafollicular or C-cells</strong> of the thyroid gland when there is increased levels of calcium in the blood</li>
<li>It <strong>reduces calcium</strong> level in the plasma
a) stimulating calcium uptake in the bone matrix (deposition in the bones)
b) inhibit reabsorption of calcium in the kidney tubules</li>
<li>The hormone is important during childhood when bones undergo changes in size</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="parathyroid-gland">Parathyroid gland<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#parathyroid-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There are four parathyroid glands, two in each lobe at posterior surface of the thyroid gland</li>
<li>They contain chief cells or principal cells which secrete parathyroid hormone.</li>
<li>Parathyroid hormone or parathormone is secreted when the blood calcium levels is low</li>
<li>Its main function is to increase ionic calcium in the blood plasma by:</li>
</ul>
<p>cont</p>
<ol>
<li>Stimulating <strong>osteoclast</strong> in the bone to digest some of the bone matrix to release ionic calcium in the blood</li>
<li>Enhance reabsorption of calcium and excretion of phosphates by kidneys</li>
<li>Increases absorption of calcium by intestinal mucosa</li>
</ol>
<p>cont</p>
<ul>
<li>Vit D is required for absorption of ca+ in the intestine.</li>
<li>For vitamin D to facilitate absorption of Ca2+, it must be converted into Vit D3 form called calcitriol and this conversion is stimulated by PTH</li>
<li>Parathormone and Calcitonin act in opposite manner to regulate normal calcium levels required for muscle contraction, blood clotting and nerve impulse transmission.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adrenal-glands">ADRENAL GLANDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adrenal-glands" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Are located at the top of the kidneys.</li>
<li>Consists of two endocrine glands:</li>
<li>outer adrenal cortex</li>
<li>inner adrenal medulla.</li>
<li>The outer adrenal cortex act more of a gland while the inner medulla act as part of autonomic nervous system</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="divisions-of-adrenal-cortex">Divisions of adrenal cortex<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#divisions-of-adrenal-cortex" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Consists of three distinct layers</p>
<ol>
<li>Zona Glomerulosa – they secretes mineralocorticoids e.g. aldosterone. This is controlled by plasma concentration of angiotensin II</li>
<li>Zona Fasciculata – middle layer and widest. secreats Glucocorticoids e.g. cortisol, corticosterone. Controlled by hypothalamic-pituitary axis through ACTH</li>
<li>Zona Reticularis – the deep layer of the adrenal cortex, mainly secretes androgens</li>
</ol>
<p>Chapter 11 – Plate Form</p>
<p><img src="assets/images/image-20251224-35379603.jpeg" alt="img-6.jpeg"></p>
<p>cont</p>
<ol>
<li>ADRENAL CORTEX;</li>
</ol>
<ul>
<li>produces three steroid hormones</li>
<li>Glucocorticoids mainly cortisol or hydrocortisone</li>
<li>Mineralocorticoids mainly aldosterone</li>
<li>Sex hormones like testosterone (androgen)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="functions-of-glucocorticoids-metabolic-effects-of-glucocorticoids">Functions of Glucocorticoids (metabolic effects of Glucocorticoids)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#functions-of-glucocorticoids-metabolic-effects-of-glucocorticoids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Gluconeogenesis – formation of new sugars from non-sugars e.g proteins</li>
<li>Carbohydrate metabolism hence raising blood sugar (hyperglycemia)</li>
<li>Reduced cell utilization of glucose</li>
<li>Lipolysis; breakdown of triglycerides into fatty acids and glycerol for energy production</li>
<li>stimulate breakdown of proteins releasing amino acids which can be used for synthesis of other proteins</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-glucocorticoids">1.GLUCOCORTICOIDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-glucocorticoids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Cortisol or hydrocortisone is the main hormone</li>
<li>Its release is stimulated by ACTH from anterior pituitary gland</li>
<li>Secretion is controlled by negative feedback system</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="glucocorticoids">Glucocorticoids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glucocorticoids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Cortisol (very potent, accounts for about 95 percent of all glucocorticoid activity)</li>
<li>Corticosterone (provides about 4 per cent of total glucocorticoid activity)</li>
<li>Cortisone (synthetic, almost as potent as cortisol)</li>
<li>Prednisone (synthetic, four times as potent as cortisol)</li>
<li>Methylprednisone (synthetic, five times as potent as cortisol)</li>
<li>Dexamethasone (synthetic, 30 times as potent as cortisol)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="physiological-and-pharmacological-effects">Physiological and pharmacological effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiological-and-pharmacological-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Anti-inflammatory actions</li>
<li>Suppression of immune responses</li>
<li>Delayed wound healing.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mineralocorticoids-aldosterone">MINERALOCORTICOIDS (ALDOSTERONE)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mineralocorticoids-aldosterone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Secreted in Zona Glomerulosa</li>
<li>Main function is regulation of electrolytes concentration in extracellular fluids particularly sodium and potassium ions</li>
<li>This is by increasing uptake of sodium from the kidney nephrone.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adrenal-medulla">ADRENAL MEDULLA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adrenal-medulla" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Produces catecholamines: epinephrine and norepinephrine</li>
<li>Epinephrine is also called Adrenaline</li>
</ul>
<p>Its functions include;</p>
<ul>
<li>it increases contraction of the heart</li>
<li>causes bronchodilation of bronchial muscles</li>
<li>causes vasoconstriction of the blood vessels</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-functions-of-catecholamines">General functions of catecholamines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-functions-of-catecholamines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Stimulate the fight or fight reaction</li>
<li>Increased plasma glucoses levels</li>
<li>Increased cardiovascular function</li>
<li>Increased metabolic function</li>
<li>Decreased gastrointestinal and genitourinary function.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pancrease">PANCREASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pancrease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There are three main types of cells found in pancreatic islet</li>
<li>Alpha cells : secrete glucagon</li>
<li>Beta cells : secrete insulin</li>
<li>Delta cells : secrete somatostatin.</li>
<li>Normal blood glucose levels is 5.5 -8.5 mmol/l</li>
<li>Blood glucose levels are control by opposing actions of insulin and glucagon</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="insulin">INSULIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#insulin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Its main function is to lower raised blood glucose levels</li>
<li>It lowers blood glucose levels by:
i. Acting on cell membrane and stimulating uptake and use of glucose by muscle and connective tissue cells
ii. Increasing conversion of glucose to glycogen (glycogenesis) for storage
iii. Signals the liver to stop releasing glucose
iv. Enhances storage of dietary fats in the adipose tissue</li>
<li>Secretion of insulin is stimulated by increased blood glucose levels e.g. after eating a meal.</li>
<li>It also inhibits glycogenolysis and gluconeogenesis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="glucagon">GLUCAGON<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glucagon" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Secretion is stimulated by low blood glucose levels and exercise</li>
<li>It promotes conversion of glycogen to glucose in liver and skeletal muscle (glycogenolysis)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="physical-examination">Physical examination<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physical-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="and">And<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#and" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="history-taking">History taking<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#history-taking" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment-of-endocrine-dysfunction">ASSESSMENT OF ENDOCRINE DYSFUNCTION.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-of-endocrine-dysfunction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Consist of Health History, Physical Examination and lab and diagnostic studies</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-health-history">1. Health History.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-health-history" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Elicit a description of client's present illness and chief complain including onset, course, location, precipitating and alleviating factors.</p>
<ul>
<li>Cardinal signs and symptoms indicating altered endocrine and metabolic function include:</li>
<li>☑ unexplained weight loss or gain</li>
</ul>
<p>cont</p>
<ul>
<li>Alteration in metabolic rate e.g. Tachycardia or bradycardia, diarrhoea or constipation.</li>
<li>Sleep pattern disturbances</li>
<li>Labile mood swings and change in mental status</li>
<li>Alteration in sexual performance</li>
</ul>
<p>b) Explore the client’s health history for risk factors associated with endocrine and metabolic disorders including</p>
<ul>
<li>☑ Family history of endocrine disorders</li>
<li>☑ Radiation therapy and trauma</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-physical-examination">2. Physical examination<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-physical-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Assess vital signs and measure body weight
b) Inspection</p>
<ul>
<li>Observe stature, fat distribution and shape of the face</li>
<li>Assess for the presence of goitre (enlarged thyroid gland)</li>
<li>Note protruding or sunken eyes and lid or retraction.</li>
</ul>
<p>cont</p>
<ul>
<li>Note the color, texture and turgor of the skin, surgical scars and unusual bruising.</li>
</ul>
<p>c) Palpation; palpate the thyroid for size, shape, symmetry and tenderness</p>
<p>d) Auscultation</p>
<ul>
<li>Auscultate heart, lung and bowel sounds</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-laboratory-and-diagnostic-studies">3. LABORATORY AND DIAGNOSTIC STUDIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-laboratory-and-diagnostic-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Measurement of hormones in the blood and urine</li>
<li>Reflects production and activity of hormones related to specific endocrine and metabolic disorders</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-laboratory-and-diagnostic-studies">3. LABORATORY AND DIAGNOSTIC STUDIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-laboratory-and-diagnostic-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-thyroid-function-tests-tfts">1. Thyroid function tests (TFTs)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-thyroid-function-tests-tfts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Measurements of TSH, T3 and T4.</p>
</li>
<li>
<p>Normal serum levels of T3 70-220ng/dl..</p>
</li>
<li>
<p>Usually done to diagnose hypothyroidism and hyperthyroidism</p>
</li>
<li>
<p>Elevated T3 and T4 with depressed TSH reflect primary hyperthyroidism.</p>
</li>
<li>
<p>Reduced T3 and T4 with depressed TSH reflect primary hypothyroidism.</p>
</li>
<li>
<p>If the TSH level is <strong>high</strong> and the FT4 result is <strong>low</strong> this suggests an <strong>under-active thyroid</strong> (hypothyroidism) that requires treatment.</p>
</li>
<li>
<p>If the TSH level is <strong>low</strong> and the FT4 result is <strong>high</strong> this suggests an <strong>over-active thyroid</strong> (hyperthyroidism) that requires treatment.</p>
</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-radioactive-iodine-uptake-test">2. Radioactive iodine uptake test<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-radioactive-iodine-uptake-test" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A client take an oral dose of a small amount radioiodine</li>
<li>over time, the iodine collects in the thyroid because thyroid uses iodine</li>
<li>It is checked after 2, 6 or 24 hrs to determine how much iodine has been absorbed by thyroid</li>
<li>Increased uptake may indicate <strong>hyperfunctioning</strong> of thyroid gland</li>
<li>Decreased uptake may indicate <strong>hypofunctioning</strong> of the gland</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-thyroid-scan">3. Thyroid scan<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-thyroid-scan" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Performed to identify nodules or growth in the thyroid gland, tumors and growths in the brain.</li>
</ul>
<p>Before thyroid scan is taken:</p>
<ul>
<li>Client is put on NPO</li>
<li>Thyroid medications are temporarily withheld</li>
<li>After the test has been done, ensure proper disposal of waste.</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-glucose-tolerance-test-gtt">4. Glucose Tolerance Test (GTT);<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-glucose-tolerance-test-gtt" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Sometimes it is called Oral Glucose Tolerance Tests (OGTT)</li>
<li>Glucose is given to patient</li>
<li>After 2 hrs, samples of blood are taken to determine how quickly it is cleared from the blood.</li>
<li>It is used to test for type 2 diabetes, insulin resistance and disorders of carbohydrate metabolism.</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="before-test">Before test:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#before-test" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Provide high carbohydrate food for 3 days</li>
<li>Instruct client to avoid alcohol, smoking and caffeine.</li>
<li>Put the client on NPO for 10 hrs before the test.</li>
<li>After test, instruct the client to avoid any strenuous activity for 8 hrs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="5-glycosylated-hemoglobin-a-1c-hba1c">5.Glycosylated hemoglobin A-1C (HBA1C)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-glycosylated-hemoglobin-a-1c-hba1c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Refers to blood glucose bound to RBCs hemoglobin.</p>
</li>
<li>
<p>Used to gauge how one is managing the Diabetes and to diagnose type one and type 2 DM.</p>
</li>
<li>
<p>It reflects average blood sugars for the last 2-3 months.</p>
</li>
<li>
<p>HBA1C measures percentage of hemoglobin coated with sugar</p>
</li>
<li>
<p>Normal HBA1C is 4%-5.6% for non-diabetic patient</p>
</li>
<li>
<p>Levels at 5.7%-6.4% indicate high risk for diabetes</p>
</li>
<li>
<p>Levels above 6.4% indicate diabetes</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disorders-of-endocrine-system">DISORDERS OF ENDOCRINE SYSTEM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders-of-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetes-mellitus-dm">DIABETES MELLITUS (DM)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetes-mellitus-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetes-mellitus">DIABETES MELLITUS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetes-mellitus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>This is a group of metabolic diseases characterized by elevated levels of glucose in the blood (hyperglycemia)</li>
<li>It results from defects in insulin secretion, insulin action or both.</li>
<li>Major sources of glucose in the body are:</li>
<li>☑ ingested food in the GIT</li>
<li>☑ formation of glucose by the liver</li>
<li>Insulin is a hormone produced by the pancreas</li>
<li>Beta cells in the islets of langerhans</li>
</ul>
<p>cont</p>
<ul>
<li>It acts by: Regulating the blood production and storage of glucose</li>
<li>In diabetic state the cells may stop responding to insulin or the pancreas may stop producing insulin entirely</li>
<li>The WHO estimates that the prevalence of DM in Kenya at 2.7% (rural) to 10.7% (urban) KDMIC, 2012)</li>
<li>It is usually prevalent in the elderly with up to 50% of people older than 65 suffering some degree of glucose intolerance</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification">Classification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) Type 1 diabetes mellitus
b) Type 2 diabetes mellitus
c) Gestational diabetes
d) Diabetes due to other conditions and syndromes</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="type-1-diabetes-mellitus">TYPE 1 DIABETES MELLITUS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#type-1-diabetes-mellitus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>The beta cells of pancreas no longer produce insulin due to destruction</p>
</li>
<li>
<p>Characterized by</p>
</li>
<li>
<p>☑ hyperglycemia,</p>
</li>
<li>
<p>☑ breakdown of body fats and protein and</p>
</li>
<li>
<p>☑ development of ketosis (Condition associated with high level of ketone bodies in the body)</p>
</li>
<li>
<p>Ketone bodies: acetone, acetoacetic acid, beta-hydroxybutyric acid, produced during the metabolism of fats.</p>
</li>
<li>
<p>Accounts for 5 – 10 % of cases of diabetes; most often occurs in childhood or adolescence</p>
</li>
<li>
<p>Formerly called Juvenile-onset diabetes or insulin-dependent diabetes (IDDM)</p>
</li>
<li>
<p>Insulin administration is a must!!</p>
</li>
</ul>
<p>ct</p>
<ul>
<li>Autoimmune destruction of beta cells arise either by genetic, immunologic or environmental factors</li>
<li>Immune mediated DM commonly develops during childhood and adolescence (juvenile onset) though it can occur at any age.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology-of-type-1-diabetes">Pathophysiology of type 1 diabetes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology-of-type-1-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There is autoimmune reaction in which the beta cells that produce insulin are destroyed.</li>
<li>Results in</li>
<li>☑ decreased insulin production,</li>
<li>☑ unchecked glucose production in the liver and</li>
<li>☑ fasting hyperglycemia.</li>
<li>☑ Alpha cells produce excess glucagon causing hyperglycemia</li>
</ul>
<p>cont</p>
<ul>
<li>
<p>Glucose derived from food fails to be stored in the liver</p>
</li>
<li>
<p>It instead stays in the blood stream</p>
</li>
<li>
<p>contributes to postprandial (after meals) hyperglycemia.</p>
</li>
<li>
<p>If the concentration of glucose in the blood exceeds the renal threshold for glucose(9.9-11.1 mmol/L),</p>
</li>
<li>
<p>The kidneys may fail to reabsorb all of the filtered glucose</p>
</li>
<li>
<p>This leads to glucosuria...sweet urine what's that??</p>
</li>
<li>
<p>When excess glucose is excreted in the urine it is accompanied by excessive loss of fluids and electrolytes (osmotic diuresis)</p>
</li>
<li>
<p>Due to shortage of glucose in the cells, the body resorts to breakdown of fats leading to formation of ketone bodies ... leads to ketoacidosis</p>
</li>
<li>
<p>Low PH</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="risk-factors-for-type-1-diabetes">Risk factors for type 1 diabetes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#risk-factors-for-type-1-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Genetic predisposition for increased susceptibility; HLA susceptibility</li>
<li>Viral infections: eg German measles, coxsackie, and mumps.</li>
<li>Race/ethnicity</li>
<li>Geography as you move away from the equator</li>
<li>Family history: if a family member has (or had) type 1, you are at a higher risk.</li>
<li>Early diet:</li>
<li>Other autoimmune conditions:</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations-of-type-1-dm">Clinical manifestations of type 1 DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations-of-type-1-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Process of beta cell destruction occurs slowly</li>
<li>hyperglycemia occurs when 80 – 90% of beta cells are destroyed; often trigger stressor event (e.g. illness)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperglycemia-leads-to">Hyperglycemia leads to:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperglycemia-leads-to" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Polyuria (hyperglycemia acts as osmotic diuretic)</li>
<li>Glucosuria (Glucose in urine).</li>
<li>Polydipsia (thirst from dehydration from polyuria)</li>
</ul>
<p>cont</p>
<ul>
<li>Polyphagia (hunger and eats more since cell cannot utilize glucose)</li>
</ul>
<p>"A patient is starved in plenty"</p>
<ul>
<li>Weight loss (body breaking down fat and protein to restore energy source)</li>
<li>Malaise and fatigue (from decrease in energy)</li>
<li>Blurred vision (swelling of lenses from osmotic effects)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="type-2-diabetes-mellitus">Type 2 Diabetes mellitus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#type-2-diabetes-mellitus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Definition: condition of fasting hyperglycemia occurring despite availability of body's own insulin</li>
<li>Is the most common type of diabetes 90-95% of the cases</li>
<li>Was known as <strong>non-insulin dependent diabetes (NIDDM)</strong> or adult onset diabetes</li>
<li>occurs due to: Impaired insulin secretion and/or Insulin resistance</li>
<li>Insulin resistance refers to <strong>decrease tissue sensitivity to insulin</strong></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology-of-type-2-dm">Pathophysiology of type 2 DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology-of-type-2-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Type 2 DM occurs due to Impaired insulin secretion and Insulin resistance</li>
<li>To overcome insulin resistance and to prevent the build up of glucose in the blood, increased amounts of insulin are secreted to maintain normalcy</li>
<li>If beta cells fail to keep up with the increased demand for insulin, the glucose level rises and type 2 DM develops</li>
</ul>
<p><img src="assets/images/image-20251224-2ec19f21.jpeg" alt="img-7.jpeg">
Impaired insulin secretion
Pancreas</p>
<p><img src="assets/images/image-20251224-b8623bef.jpeg" alt="img-8.jpeg">
Gastrointestinal absorption of glucose</p>
<p><img src="assets/images/image-20251224-8c3c3afe.jpeg" alt="img-9.jpeg">
Hyperglycemia
Liver
Increased basal hepatic glucose production</p>
<p><img src="assets/images/image-20251224-f812e39a.jpeg" alt="img-10.jpeg">
Muscle
Decreased insulin-stimulated glucose uptake</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="risk-factors-for-type-2-dm">Risk factors for type 2 DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#risk-factors-for-type-2-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>History of diabetes in parents or siblings; no HLA</li>
<li>Obesity (especially of upper body)</li>
<li>Physical inactivity</li>
<li>Race/ethnicity: African American, Hispanic, or American Indian origin</li>
<li>Women: history of gestational diabetes,</li>
<li>Clients with hypertension; HDL cholesterol &lt; 35 mg/dL, and/or triglyceride level &gt; 250 mg/dL</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="manifestations-of-type-2-dm">Manifestations of type 2 DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations-of-type-2-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Most patients present with the classical symptoms of diabetes, including</p>
</li>
<li>
<p>☑ polyuria,</p>
</li>
<li>
<p>☑ polydypsia and</p>
</li>
<li>
<p>☑ polyphagia (the 3P’s)</p>
</li>
<li>
<p>Additionally, some patients present with diabetic coma (hyperosmolar hyperglycemic non-ketotic states).</p>
</li>
<li>
<p>In type 2 DM there is enough insulin present to prevent the breakdown of fats hence ketone bodies are not present</p>
</li>
<li>
<p>Uncontrolled type 2 DM leads to Hyperglycemic hyper osmolar non ketotic syndrome (HHNKS)</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="gestational-diabetes">Gestational diabetes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gestational-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>This is any degree of glucose intolerance with its onset in pregnancy</li>
<li>Hyperglycemia develops in pregnancy because of secretion of placental hormones which causes insulin resistance</li>
<li>All pregnant women who meet the following criteria should be screened for DM:</li>
<li>Obese, age 25 years or older, age 25 year or younger and a history of DM in first degree relatives</li>
<li>It occurs in up to 14% of pregnant women and increases the risk for hypertensive disorders in pregnancies.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="signs-and-symptoms">Signs and symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>All types of diabetes have the 3P’s polyuria, polydipsia and polyphagia</li>
<li>Others, fatigue, weakness, vision changes, numbness in the hands or the feet, skin lession or wound that are slow to heal</li>
<li>Recurrent infection</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment-and-diagnostic-findings">Assessment and diagnostic findings<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-and-diagnostic-findings" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>History taking</li>
<li>Physical examination: BP, BMI, neurologic exam etc</li>
<li>Lab finding</li>
<li>High fasting plasma glucose (6.0 mmol/L or more)</li>
<li>RBS of 11.1 mmol/L or more</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="history-taking">History taking<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#history-taking" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Diabetic history, both recent and historical</li>
<li>Symptoms of potential complications e.g. deterioration in eyesight</li>
<li>Drug history, current medications</li>
<li>Family history</li>
<li>Occupation and social history e.g. level of exercise, type of diet,</li>
<li>Smoking history, use of alcohol and recreational drugs</li>
<li>Prior knowledge of, attitudes to and concerns about the condition</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examination">Examination<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="general-examination">General examination<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Height/ weight/ BMI</li>
<li>Examination of feet (e.g. ulcers, loss of sensation)</li>
<li>Examination of eyes (e.g. cataracts, diabetic retinopathy)</li>
<li>Blood pressure measurement</li>
<li>Examination of peripheral pulses</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnosis-of-dm">DIAGNOSIS OF DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnosis-of-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The diagnosis of diabetes must be confirmed biochemically prior to initiation of any therapy,</li>
<li>The presence of symptoms of hyperglycaemia, such as polyuria, polydypsia, lethargy, loss of weight and a random blood glucose (RBS) equal or above 11.1 mmol/L</li>
<li>Or a fasting capillary whole blood glucose &gt;6.1 mmol/L or more fasting blood sugar (FBS)</li>
<li>confirms the diagnosis of diabetes!</li>
<li>LOWER LIMIT for blood sugar is 3.3mmol/L</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnosis-of-dm-in-asymptomatic-individuals">Diagnosis of dm in asymptomatic individuals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnosis-of-dm-in-asymptomatic-individuals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In asymptomatic subjects a single abnormal blood glucose result is inadequate to make a diagnosis of diabetes.</li>
<li>The abnormal value must be confirmed at the earliest possible date using any of the following:
a) Fasting or random blood sample on two separate occasions or
b) a 75 g oral glucose tolerance test...</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management">MANAGEMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aim">Aim:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aim" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To normalize insulin activity and blood glucose levels (euglycaemia) without hypoglycemia and without seriously disrupting the patient’s usual lifestyle and activity</li>
<li>To reduce development of vascular and neuropathic complications</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="components-of-dm-management">COMPONENTS OF DM MANAGEMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#components-of-dm-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Pharmacologic therapy(Medical management)</p>
</li>
<li>
<p>Nutritional management</p>
</li>
<li>
<p>Exercise</p>
</li>
<li>
<p>Monitoring</p>
</li>
<li>
<p>Education</p>
</li>
<li>
<p>PHARMACOLOGIC THERAPY (MEDICAL MANAGEMENT)</p>
</li>
</ol>
<p>Consist of :-
a). oral glucose lowering agents
b). insulin therapy</p>
<p>a) Oral Glucose Lowering Agents (OGLAs)</p>
<ul>
<li>were previously referred to as oral hypoglycaemic agent</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications">Indications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Failure of lifestyle modifications</li>
<li>Fasting blood glucose level &gt; 11 mmol/L</li>
<li>Random blood glucose level &gt; 15 mmol/L.</li>
<li>When an individual's glycaemic targets are not met by the combination of dietary, modifications and physical activity/exercise.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classes-of-oral-hypoglycemic-agents">Classes of oral hypoglycemic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classes-of-oral-hypoglycemic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Sulphonylureas</li>
<li>Biguanide</li>
<li>Thiazolidinediones</li>
<li>Meglitinides</li>
<li>Alpha_glucosidase inhibitors</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-sulphonyiureas">1. Sulphonyiureas<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-sulphonyiureas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Action: Stimulates pancreatic cells to secrete more insulin and increases sensitivity of peripheral tissues to insulin</li>
<li>Used: to treat non-obese Type 2 diabetes</li>
<li>Example: Glibenclamide, Glipizide (Glucotrol), Chlorpropamide (Diabinese), Glimepiride : Gliclazide, Tolazamide (Tolinase)</li>
</ul>
<p>a) Glibenclamide</p>
<p>Starting Dose: 2.5 mg
Maximal dose: 15 mg
Major S/E: Hypoglycaemia* weight gain, skin rashes
C/I: Caution in liver and renal disease</p>
<p>b) Glipizide</p>
<p>Starting Dose: 5 mg
Maximal dose: 40 mg
Major S/E: Hypoglycaemia* weight gain, skin rashes
C/I: Caution in PG, liver and renal disease</p>
<p>c) Chlorpropamide: 250mg- 500mg</p>
<p>S/E : Hypoglycaemia* weight gain Skin rashes</p>
<p>C/I : Pregnancy, caution in liver and renal disease :</p>
<p>Others are</p>
<p>d) Glimepiride : 1mg-8mg</p>
<p>e) Gliclazide ; 40mg-320mg</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-biguanides">2. BIGUANIDES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-biguanides" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Action: decreases overproduction of glucose by liver and makes insulin more effective in peripheral tissues</li>
<li>Used in obese diabetics</li>
<li>Does not stimulate insulin release</li>
<li>Metabolized by the kidney, do not use with renal patients</li>
<li>Example: Metformin (Glucophage)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Metformin : 500mg -2550mg</li>
<li>S/E : Abdominal pain, nausea, loose bowel motions lactic acidosis, increased flatulence</li>
<li>C/I : Renal, heart and liver failure;</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-meglitinides">3. Meglitinides<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-meglitinides" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Action: stimulates pancreatic cells to secret more insulin</li>
<li>Taken just before meals, rapid onset, limited duration of action</li>
<li>Major adverse effects is hypoglycemia</li>
<li>Used in non-obese diabetics</li>
<li>Example: Repaglinide (Prandin), Nateglinide (Starlix)</li>
</ul>
<p>Repaglinide : 1.0 mg -16mg</p>
<ul>
<li>S/E : Liver impairment, fluid retention, weight gain, anaemia</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-thiazolidine-diones">4. THIAZOLIDINE DIONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-thiazolidine-diones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Action: Sensitizes peripheral tissues to insulin</li>
<li>Used in obese diabetics</li>
<li>Inhibits glucose production</li>
<li>Improves sensitivity to insulin in muscle, and fat tissue</li>
<li>Example: Rosiglitazone (Avandia), Pioglitazone (Actos)</li>
</ul>
<p>a) Rosiglitazone : 4mg - 8mg</p>
<p>S/E : Liver impairment, fluid retention weight gain, anaemia, hypotension, death, heart failure</p>
<p>C/I : Renal, heart and liver failure; cardiac disease class III and IV, pregnancy</p>
<p>b) Pioglitazone : 15mg - 45mg</p>
<p>S/E : Liver impairment, fluid retention weight gain, anaemia, Renal, heart and liver failure; pregnancy</p>
<ol start="5">
<li>ALPHA_GLUCOSIDASE INHIBATORS</li>
</ol>
<ul>
<li>Action: Slow carbohydrate digestion and delay rate of glucose absorption</li>
<li>Take with first bite of the meal or 15 min. after</li>
<li>Adjunct to diet to decrease blood glucose levels</li>
</ul>
<p>Example: Acarbose (Precose), Miglitol (Glyset)</p>
<p>Acarbose: 25mg - 300mg</p>
<ul>
<li>S/E: Dyspepsia loose bowel motions, Flatulence</li>
</ul>
<p>PRECAUTIONS WHEN USING ORAL HYPOGLYCEMIC AGENTS</p>
<ul>
<li>If overweight (BMI &gt; 25 kg/m2) Metformin should be the first choice.</li>
<li>If Metformin is contraindicated, thiazolidinediones may be used</li>
<li>Long-acting sulphonylureas should be avoided in elderly patients.</li>
<li>In such patients, use short-acting sulphonylureas such as glimepiride, gliclazide</li>
</ul>
<p>CONT</p>
<ul>
<li>Metformin should be used with care in the elderly (over the age of 75 years) and is contraindicated in people with elevated serum creatinine, liver disease and severe respiratory, cardiac and peripheral vascular disease</li>
<li>Combination therapy using OGLAs with different mechanisms of action is indicated if monotherapy with one of the agents has failed.</li>
</ul>
<p>B) INSULIN THERAPY</p>
<ul>
<li>In type 1 diabetes, exogenous insulin is a must to be administered for life because the body looses ability to produce insulin.</li>
<li>In type 2 diabetes, insulin may be necessary on long term basis to control glucose levels if meal planning and oral agents are in effective.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="insulin">Insulin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#insulin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>10 ml</p>
<p><img src="assets/images/image-20251224-db2c689f.jpeg" alt="img-11.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications-of-insulin-therapy">Indications of insulin therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications-of-insulin-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) All type 1 diabetics since their bodies essentially no longer produce insulin</p>
<p>b) Some Type 2 diabetics, if oral medications are not adequate for control (both oral medications and insulin may be needed)</p>
<p>c) Diabetics enduring stressor situations such as surgery, corticosteroid therapy, infections, treatment for DKA, HHNKS</p>
<p>d) Women with gestational diabetes who are not adequately controlled with diet</p>
<p>cont</p>
<p>PREPARATIONS</p>
<ul>
<li>A number of insulin preparations are available</li>
<li>They vary according to their characteristics : time of course of action, sources or species and manufacturers.</li>
</ul>
<p>TIME COURSE OF ACTION</p>
<ul>
<li>Insulin may be grouped into four main categories based on onset, peak and duration of action.</li>
<li>They are:
Rapid acting, Short acting, intermediate and long acting insulin.</li>
</ul>
<p>cont</p>
<p>a) Rapid acting insulins produce a more rapid effect that is of shorter duration.</p>
<ul>
<li>Because of rapid onset, the patient should be instructed to eat within 5 to 15 minutes after injection.</li>
<li>Due to short action period, the patient requires long acting insulin to maintain glucose control</li>
<li>Basal insulin is required to maintain glucose control</li>
<li>Intermediate-acting insulins function as basal insulins. Basal insulin works day and night to control blood sugar between meals and during sleep.</li>
<li>They keep blood glucose at a consistent levels during fasting</li>
</ul>
<p>cont</p>
<p>b) Short acting insulin are called regular insulin. Regular insulin is a CLEAR solution and is usually administered 20-30 minutes before meal. It is the only insulin approved for IV use.</p>
<p>c) Intermediate acting insulin are also called NPH (Neutral Protamine Hagedorn), they are similar in their time course of action, but appear WHITE AND CLOUDY</p>
<p>d) In long acting insulins, insulin is absorbed very slowly over 24hrs and can be given once a day.</p>
<p>Types of insulin and their properties</p>
<table><thead><tr><th>Insulin preparation</th><th>Onset of action (hrs.)</th><th>Peak action</th><th>Duration of action (hrs.)</th><th>Injections per day</th></tr></thead><tbody><tr><td>Rapid-acting</td><td>10-20 min</td><td>1-2</td><td>3-5</td><td>Immediately before meals or with meals</td></tr><tr><td>Short acting</td><td>30-60 min</td><td>2-4</td><td>6-8</td><td>30 min before meals</td></tr><tr><td>Intermediate (NPH)</td><td>1-2h</td><td>5-7</td><td>13-18</td><td>Once or twice</td></tr><tr><td>Long acting</td><td>1-2 hours</td><td>peakless</td><td>24 h</td><td>Once</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="insulins-available-in-local-market">Insulins available in local market<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#insulins-available-in-local-market" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Insulin preparation</th><th>Examples available in the market</th><th></th></tr></thead><tbody><tr><td>Rapid-acting</td><td>Humalog or lispro, Novolog or aspart, Apidra or glulisine</td><td>Rapid-acting insulin covers insulin needs for meals eaten at the same time as the injection</td></tr><tr><td>Short Acting (soluble)</td><td>Regular (R) humulin or novolin, Velosulin (for use in the insulin pump)</td><td>Short-acting insulin covers insulin needs for meals eaten within 30-60 minutes</td></tr><tr><td>Intermediate</td><td>Humulin N (NPH (N)) Novolin N Lente</td><td>Intermediate-acting insulin covers insulin needs for about half the day or overnight.</td></tr></tbody></table>
<p>cont</p>
<table><thead><tr><th>Biphasic mixture 30/70 Premixed insulin)*</th><th>Humulin 70/30, Novolog 70/30, Novolin 70/30</th><th>Twice a day before meal time</th></tr></thead><tbody><tr><td>Long acting</td><td>Lantus/Glargine Levemir/ Detemir Ultralente</td><td>Once a day</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pre-mixed-insulin">Pre-mixed insulin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pre-mixed-insulin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pre-mixed insulin contain a combination of a rapid acting and intermediate acting insulin in fixed proportion.</li>
<li>This product eliminates difficult encountered while mixing two preparations of insulin</li>
<li>It indicated in ratios and first ratio indicate rapid or short acting while the second ratio indicate intermediate acting</li>
</ul>
<p>examples are : Humulin 70/30, Novolog 70/30, Novolin 70/30. are called biphasic mixtures.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="supplemental-insulin-therapy">Supplemental insulin therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#supplemental-insulin-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Supplement oral hypoglycemic agents</li>
<li>Intermediate acting insulin is given at 10pm</li>
<li>Total Daily Dose calculated by: Kg x 0.2 IU of insulin (70 kg patient x 0.2 IU = 14 IU insulin).</li>
<li>The OGLAs are continued (half maximum dose of sulphonylureas and metformin dose of 2 g/day, or the sulphonylureas stopped and metformin continued).</li>
<li>Monitor blood glucose levels when possible.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="substitution-insulin-therapy">Substitution insulin therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#substitution-insulin-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Oral hypoglycemic are discontinued .(unless the patient is obese where METFORMIN will be continued),</li>
<li>PRE-MIXED insulin is introduced twice daily at a dosage of 0.2 IU/kg body weight.</li>
<li>This is split into 2/3 in the morning and 1/3 in the evening, at 30 minutes before the morning and the evening meals.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="health-messages-shared-to-the-patient-discharged-with-mixtard">Health messages shared to the patient discharged with mixtard.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#health-messages-shared-to-the-patient-discharged-with-mixtard" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A patient discharge on mixtard to be used at home should be taught on the following</p>
<ul>
<li>Use of insulin syringes and how to withdraw the right dose.</li>
<li>How to administer through the right route</li>
<li>Sites of insulin administration, show the patient all sites in the body where insulin can be administered.</li>
<li>Teach the patient on signs and symptoms of hypoglycemia.</li>
<li>Teach the patient to carry sweeteners or glucose in case of hypoglycemia</li>
<li>Teach the patient on how to store insulin in cold place.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="human-mixtard">HUMAN MIXTARD<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#human-mixtard" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Brand Of NOVO NORDISK Denmark based company.</p>
</li>
<li>
<p>Indication in case of Diabetes Mellitus.</p>
</li>
<li>
<p>Human Mixtard contains Premixed Human Insulin. (30:70 &amp; 50:50)</p>
</li>
<li>
<p>30% Regular Insulin &amp; 70% NPH Insulin.</p>
</li>
<li>
<p>50% Regular Insulin &amp; 50% NPH Insulin</p>
</li>
<li>
<p>Its available as Human Mixtard 30 and Human Mixtard 50.</p>
</li>
<li>
<p>Keep out of the reach and sight of children</p>
</li>
<li>
<p>Read the package leaflet before use</p>
</li>
<li>
<p>Resuspend according to instructions</p>
</li>
<li>
<p>Store in a refrigerator (2°C - 8°C)</p>
</li>
<li>
<p>Do not freeze</p>
</li>
<li>
<p>Keep the vial in the outer carton in order to protect from light</p>
</li>
<li>
<p>After first opening: Use within 6 weeks when stored below 25°C or 5 weeks when stored below 30°C. Do not refrigerate</p>
</li>
<li>
<p>Discard the needle after each injection</p>
</li>
</ul>
<p>Mixtard® 30</p>
<p>100 IU/ml</p>
<p>Suspension for injection
Insulin human (rDNA)</p>
<p>SC use
SIN08656P</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications-of-insulin-therapy">Complications of insulin therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-insulin-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Local allergic reaction characterised by redness, swelling, tenderness and indurations of 2-4 cm wheal may appear 1 to 2 hrs after insulin administration at the site of injection. Physician may prescribe antihistamine to be taken 1 hr before injection.</li>
<li>Systemic allergic reaction: are rare, but when they occur, there is immediate local skin reaction that gradually spreads into generalised urticaria (hives)</li>
<li>Treatment involves desensitization with small doses of insulin administered in gradually increasing amount using desensitization kit.</li>
</ul>
<p>cont</p>
<ul>
<li>
<p>Insulin lipodystropy : loss of subcutaneous fat tissue that can occur as a result of repeated insulin injections at the same site.</p>
</li>
<li>
<p>Insulin resistance ; physiological condition in which cells of the body fails to respond to normal action of insulin.</p>
</li>
<li>
<p>clinically, it is defined as a daily insulin requirement of 200iu units or more. Immune antibodies develop and bind to the insulin, thereby decreasing insulin available for use.</p>
</li>
<li>
<p>Hypoglycemia: most common complication due to delay in taking a meal or using too much insulin.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="signs-and-symptoms-includes">Signs and symptoms includes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms-includes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Shakiness Nervousness or anxiety Sweating,</p>
</li>
<li>
<p>chills and clamminess</p>
</li>
<li>
<p>Irritability or impatience</p>
</li>
<li>
<p>Confusion, including delirium</p>
</li>
<li>
<p>Rapid/fast heartbeat</p>
</li>
<li>
<p>Lightheadedness or dizziness</p>
</li>
<li>
<p>Hunger and nausea</p>
</li>
<li>
<p>Sleepiness</p>
</li>
<li>
<p>Blurred/impaired vision</p>
</li>
<li>
<p>Tingling or numbness in the lips or tongue</p>
</li>
<li>
<p>Headaches</p>
</li>
<li>
<p>Weakness or fatigue</p>
</li>
<li>
<p>Anger,</p>
</li>
<li>
<p>stubbornness, or sadness</p>
</li>
<li>
<p>Lack of coordination</p>
</li>
<li>
<p>Nightmares or crying out during sleep</p>
</li>
<li>
<p>Seizures Unconsciousness</p>
</li>
<li>
<p>All of the manifestations of hypoglycemia are rapidly relieved by glucose administration.</p>
</li>
<li>
<p>If more severe hypoglycemia has produced unconsciousness or stupor, the treatment is 50 mL of 50% glucose solution by rapid intravenous infusion</p>
</li>
<li>
<p>If there is hypoglycemia without loss of consciousness, the patient can be given 15 or 20g of fast acting carbohydrate such as orange juice</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-nutritional-management">2. Nutritional management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-nutritional-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Nutrition, diet and weight control are the foundation of DM management</li>
<li>The aim is to control the total caloric intake, to attain or maintain a reasonable body weight and control blood glucose levels (Greatly helps manage type 2 DM)</li>
</ul>
<p>GOALS:</p>
<ul>
<li>To provide all the essential food constituents necessary for optimal nutrition</li>
<li>To meet energy needs and maintain reasonable weight</li>
<li>Prevent wide fluctuations in blood glucose levels</li>
<li>To decrease serum lipid levels, if elevated and to reduce the risk of macro vascular disease</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="caloric-requirements">Caloric requirements<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#caloric-requirements" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Calorie controlled diets are planned by first calculating the individual energy needs and caloric requirements based on the patient’s age, gender, height and weight</li>
<li>An activity element is factored in to provide the actual number of calories required</li>
</ul>
<p>cont</p>
<ul>
<li>Currently caloric requirements are that the patients should take 0-60% carbohydrates, 20-30% from fat and 10-20% from protein</li>
<li>Recommendations regarding fat content is to reduce amount of saturated fats to 10% of total calories, limiting the total intake of cholesterol to less than 300mg/day</li>
<li>The meal plan for protein should include use of non animal sources of protein.</li>
<li>Use food guide pyramid to help patient with DM</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principles-of-dietary-management-of-type-2-diabetes-mellitus">Principles of dietary management of Type 2 diabetes mellitus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-dietary-management-of-type-2-diabetes-mellitus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pure (simple) sugars in foods and drinks should be avoided</li>
<li>At least three meals a day should be eaten, and binge eating should be avoided</li>
<li>Food quantities should be measured in volumes using available household items, such as cups, or be countable, such as number of fruits or slices of yam or bread.</li>
<li>Alcohol should be avoided.</li>
<li>Sweeteners are not essential and should be avoided as much as possible.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-exercise">3. EXERCISE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-exercise" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Exercise lowers the blood glucose level by increasing the uptake of glucose by body muscles and by improving insulin utilization</li>
<li>It also improves circulation and muscle tone</li>
<li>It also alters blood lipid levels, increasing the levels of high density lipoproteins and decreasing total cholesterol and triglyceride levels</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-recommendations-for-exercise-in-dm">General recommendations for exercise in DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-recommendations-for-exercise-in-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Exercise at the same time, preferably when blood glucose levels are at their peak and the same amount each day</li>
<li>Regular exercise, rather than sporadic exercise should be encouraged</li>
<li>Use proper footwear and if appropriate other protective equipment</li>
<li>Avoid exercise in extreme heat or cold</li>
<li>Inspect feet daily after exercise</li>
<li>For patients older than 30 years and who have two or more risk factors for heart disease, an exercise stress test is essential</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The physical activity should be regular (-3 days/week), last at least 20-30 min. per session, and be of at least moderate activity</li>
<li>Activities like walking, climbing steps (instead of taking lifts) should be encouraged.</li>
<li>For sedentary persons with diabetes, a gradual introduction using a low-intensity activity like walking is mandatory.</li>
<li>Avoid strenuous exercise if ambient glycaemia is &gt;250 mg/dl (14 mmol/L), the patient has ketonuria or blood glucose is less than 8mg/dl (4.5mmol/L),</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="exercise-precautions-in-dm-patients">EXERCISE PRECAUTIONS IN DM PATIENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#exercise-precautions-in-dm-patients" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Glycaemia (BLOOD SUGARS) should be monitored (using strips and meters) before and after planned strenuous physical activity as delayed hypoglycemia may occur.</li>
<li>Proper footwear must always be worn</li>
<li>Avoid strenuous exercise if ambient glycaemia is &gt; 250 mg/dl (14mmol/L), the patient has ketonuria or blood glucose is less than 80mg/dl (4.5mmol/l)</li>
<li>Avoid exercise in extreme heat or cold</li>
</ul>
<ol start="4">
<li>Monitoring blood sugars</li>
</ol>
<ul>
<li>Important through self monitoring of blood glucose (SMBG)</li>
<li>Patients are instructed to keep a record or logbook of blood glucose levels so that they can detect patterns</li>
<li>Testing is done at the peak action time of medication to evaluate the need for dosage adjustments</li>
</ul>
<ol start="5">
<li>Diabetic education</li>
</ol>
<ul>
<li>Diabetes education is the provision of knowledge and skill to people with diabetes that will empower them to render self-care in the management of their diabetes and associated disorders.</li>
</ul>
<p>HEALTH MESSAGES SHARED INCLUDE:</p>
<ul>
<li>What foods to eat, how much and how often to eat, how to exercise and its precautions, how and when to take medications</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>How to look after their feet, and thus prevent ulcers and amputations</li>
<li>How to avoid other long-term complications</li>
<li>That regular medical check ups are essential</li>
<li>When to seek medical help, e.g. How to identify hypoglycaemic and hyperglycaemic emergencies and symptoms, as well as signs of chronic complications</li>
<li>That diabetes is serious chronic disease, has no cure, but can be controlled</li>
</ul>
<p>Chart 41-7 • PATIENT EDUCATION</p>
<p>Self-Injection of Insulin</p>
<ol>
<li>With one hand, stabilize the skin by spreading it or pinching up a large area.</li>
</ol>
<p><img src="assets/images/image-20251224-bd904cf6.jpeg" alt="img-12.jpeg">
Pinching the skin</p>
<ol start="2">
<li>Pick up syringe with the other hand and hold it as you would a pencil. Insert needle straight into the skin.*</li>
</ol>
<p><img src="assets/images/image-20251224-5c0c4759.jpeg" alt="img-13.jpeg">
Inserting the needle into the skin</p>
<ol start="3">
<li>To inject the insulin, push the plunger all the way in.</li>
</ol>
<p><img src="assets/images/image-20251224-069224be.jpeg" alt="img-14.jpeg">
Injecting the insulin</p>
<ol start="4">
<li>Pull needle straight out of skin. Press cotton ball over injection site for several seconds.</li>
</ol>
<p><img src="assets/images/image-20251224-861c6e1d.jpeg" alt="img-15.jpeg">
Removing the needle and holding cotton ball over site</p>
<ol start="5">
<li>Use disposable syringe only once and discard into hard plastic container (with a tight-fitting top) such as an empty bleach or detergent container.† Follow state regulations for disposal of syringes and needles.</li>
</ol>
<p><img src="assets/images/image-20251224-882f641f.jpeg" alt="img-16.jpeg">
Disposing of syringe</p>
<p>*Some patients may be taught to insert the needle at a 45-degree angle.</p>
<p>†Although some studies suggest that reusing disposable syringes may be safe, it is recommended that this be done only in the absence of poor personal hygiene, an acute concurrent illness, open wounds on the hands, or decreased resistance to infection.</p>
<p><img src="assets/images/image-20251224-fd6a6297.jpeg" alt="img-17.jpeg">
GURE 41-7 Suggested areas for insulin injection.</p>
<p><img src="assets/images/image-20251224-71e3c710.jpeg" alt="img-18.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management-of-a-patient-with-dm">NURSING MANAGEMENT OF A PATIENT WITH DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management-of-a-patient-with-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Monitor fasting and random blood sugars daily and document the results in the cardex</li>
<li>Administer prescribed insulin, metformin and other sulphonylureas as prescribed in the treatment sheet.</li>
<li>Continuous monitoring of patient for signs of acute and chronic complications of diabetes.</li>
<li>Provide a balance diabetic diet that contain carbohydrates, protein, with less saturated fats.</li>
<li>Encourage patient to do physical activities like walking and climbing steps</li>
</ul>
<p>cont</p>
<ul>
<li>Initiate safety precautionary measures to prevent injury to the feet of the patient by providing foot wears.</li>
<li>Provide health education to the patient on recognition of signs and symptoms of hypoglycemia and hyperglycemia, exercises and kind of food to eat.</li>
<li>Monitor vitals signs to include BP, R, T, and pulse.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acute-complications-of-dm">Acute complications of DM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acute-complications-of-dm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There are three major acute complications of DM related to short term imbalances in blood glucose levels</li>
</ul>
<p>They include :</p>
<ul>
<li>Hypoglycemia</li>
<li>Diabetic ketoacidosis (DKA)</li>
<li>Hyperglycemic hyperosmolar non ketotic syndrome (HHNS)</li>
</ul>
<ol>
<li>HYPOGLYCEMIA</li>
</ol>
<ul>
<li>Refers to low blood sugar</li>
<li>Occurs when the blood sugar falls below 3.3mmol/l</li>
<li>Occurs when insulin is at their peak levels</li>
<li>Severe hypoglycemia is a medical emergency</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">CAUSEs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To much insulin</li>
<li>Oral hypoglycemic agents</li>
<li>Excessive physical activity</li>
<li>Little food.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-manifestations">CLINICAL MANIFESTATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>grouped into two categories:
a) adrenergic symptoms and
b) central nervous system (CNS) symptoms..</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In mild hypoglycemia, as the blood glucose level falls, the sympathetic nervous system is stimulated, resulting in a surge of epinephrine and norepinephrine.</li>
<li>This causes symptoms such as sweating, tremor, tachycardia, palpitation, nervousness and hunger.</li>
<li>In moderate hypoglycemia, the fall in blood glucose level deprives the brain cells of needed fuel for functioning</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Signs of impaired function of the CNS may include inability to concentrate, headache, lightheadedness, confusion, memory lapses, numbness of the lips and tongue, slurred speech, impaired coordination, emotional changes, irrational or combative behavior, double vision and drowsiness.</p>
</li>
<li>
<p>Any combination of these symptoms (in addition to adrenergic symptoms) may occur with moderate hypoglycemia</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">CONT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In severe hypoglycemia, CNS function is so impaired</li>
<li>Symptoms may include disoriented behavior, seizures, difficulty arousing from sleep, or loss of consciousness</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="treatment-for-mild-hypoglycemia">Treatment for mild hypoglycemia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment-for-mild-hypoglycemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) Immediate treatment: client should take 15 gm of rapid-acting sugar (half cup of fruit juice; glucose powder)
b) 15/15 rule: wait 15 minutes and monitor blood glucose; if still low, client should eat another 15 gm of sugar
c) Continue until blood glucose level has returned to normal</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management-of-severe-hypoglycemia">Management of severe hypoglycemia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management-of-severe-hypoglycemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) If client is conscious and alert, administer 5% or 10% dextrose infusion, if no dextrose, administer 15gm im glucagon
b) Monitor blood sugars until they become stable.
c) If client is unconscious, administer 10 mls of 50% bolus dextrose followed by 5% infusion
d) Monitor client response physically and also blood glucose level</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetic-ketoacidosis-dka">Diabetic ketoacidosis (DKA)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetic-ketoacidosis-dka" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>DKA is caused by an absence or markedly inadequate amount of insulin.</li>
<li>It is a medical emergency</li>
<li>Results from breakdown of fat and overproduction of ketones by the liver and loss of bicarbonate</li>
<li>Common in type 1 DM but also type 2 are at risk</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Decreased or missed dose of insulin,</li>
<li>Illness or infection,</li>
<li>Undiagnosed and untreated diabetes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="common-precipitating-factors">Common Precipitating Factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-precipitating-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Include:</p>
<ul>
<li>UTI, URTI, gastroenteritis</li>
<li>Poor patient compliance with medication, or not increasing insulin when needed</li>
<li>Myocardial infarction, CVA</li>
<li>Thromboembolic disorders</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology-of-dka">Pathophysiology of DKA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology-of-dka" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Without insulin, the amount of glucose entering the cells is reduced and the liver :</li>
<li>Increases glucose production leading to hyperglycemia and</li>
<li>Breakdown of fat (lipolysis) into free fatty acids and glycerol leading formation of ketones</li>
<li>In an attempt to rid the body of the excess glucose, the kidneys excrete glucose along with water and electrolytes (eg, sodium and potassium) leading to osmotic diuresis.</li>
</ul>
<p>cont</p>
<ul>
<li>This osmotic diuresis, which is characterized by excessive urination (polyuria), leads to dehydration and marked electrolyte loss.</li>
<li>The Liver breakdown fat (lipolysis) into free fatty acids and glycerol. The free fatty acids are converted into ketone bodies by the liver</li>
<li>Ketone bodies are three product acetone, acetoacacetic acid and beta hydroxybutyric acid.</li>
<li>They are therefore acids; their accumulation in the circulation leads to metabolic acidosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestation-of-dka">Clinical manifestation of DKA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestation-of-dka" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The three main clinical features of DKA are:</p>
<ul>
<li>Hyperglycemia</li>
<li>Dehydration and electrolyte loss</li>
<li>Acidosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="others-are">OTHERS ARE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#others-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Kussmals respirations .deep urge to breath...air hunger</li>
<li>Deep breathing without labored breathing in an attempt to Blow off carbon dioxide to reverse acidosis</li>
<li>Fruity breath... Sweet breath</li>
<li>Nausea/ abdominal pain</li>
</ul>
<p>cont</p>
<ul>
<li>
<p>Dehydration</p>
</li>
<li>
<p>Lethargy</p>
</li>
<li>
<p>Coma</p>
</li>
<li>
<p>Polydipsia, polyuria, polyphagia</p>
</li>
<li>
<p>Patients with marked intravascular volume depletion may have orthostatic hypotension (drop in systolic blood pressure of 20 mm Hg or more on standing).</p>
</li>
<li>
<p>Volume depletion may also lead to frank hypotension with a weak, rapid pulse.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnostic-findings">Diagnostic findings<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnostic-findings" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Blood glucose levels may vary from 300 to 800 mg/dl (16.6 to 44.4 mmol/L).</li>
<li>Low serum bicarbonate (0 to 15 meq/l)</li>
<li>Low pH (6.8 to 7.3) values</li>
<li>Low PCO2 level (10 to 30 mm hg) reflects respiratory compensation (kussmaul respirations) for the metabolic acidosis.</li>
<li>Elevated levels of creatinine, blood urea nitrogen (bun)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="areas-of-focus-in-management-of-dka">AREAS OF FOCUS IN MANAGEMENT OF DKA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#areas-of-focus-in-management-of-dka" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Restoration of fluid balance</li>
<li>Correction of acidosis</li>
<li>Correction electrolyte imbalance</li>
</ol>
<p>Management involves</p>
<ul>
<li>Rehydration</li>
<li>Insulin injection</li>
<li>Monitoring of blood glucose, input and output, vital signs and arterial blood gases</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emergency-management">Emergency management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emergency-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Insulin is usually infused intravenously at a slow, continuous rate (eg, 5 units per hour).</li>
<li>Monitor blood glucose hourly</li>
<li>0.9% sodium chloride (normal saline) solution is administered at a rapid rate, usually 0.5 to 1 L per hour for 2 to 3 hours. Half-strength normal saline (0.45%) solution (also known as hypotonic saline solution) may be used for patients with hypertension or hypernatremia or those at risk for heart failure</li>
</ol>
<p>cont</p>
<ol start="4">
<li>Monitoring fluid volume status and electrolytes levels and document the input and output</li>
<li>Monitor vital signs and arterial blood gases (including monitoring for orthostatic changes in blood pressure and heart rate), lung assessment.</li>
<li>Continuously assess the patient for the response to the ongoing treatment and for signs of hyperkalemia and document the findings</li>
</ol>
<p>NB : Bicarbonate infusion to correct severe acidosis is avoided during treatment of DKA because it precipitates further, sudden (and potentially fatal) decreases in serum potassium levels. :</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperglycemic-hyperosmolar-non-ketotic-syndrome-hhnks">HYPERGLYCEMIC HYPEROSMOLAR NON-KETOTIC SYNDROME (HHNKS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperglycemic-hyperosmolar-non-ketotic-syndrome-hhnks" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Potential complication of type 2 diabetes that involves extremely high blood sugars without presence of ketones</li>
<li>In this condition, enough insulin is secreted to prevent ketosis, but not enough to prevent hyperglycemia</li>
<li>Life threatening medical emergency, high mortality rate, as high as 50% occurs</li>
<li>most often in older people (ages 50 to 70) with no known history of diabetes or with type 2 diabetes.</li>
<li>Hyperosmolarity is a condition in which has high conc. of salt, glucose and other substances that draws water out of other organs to blood stream.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="precipitating-factors">Precipitating factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#precipitating-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Acute illness (eg, pneumonia or stroke)</li>
<li>Medications that exacerbate hyperglycemia (thiazides)</li>
<li>Treatments, such as dialysis</li>
<li>The history includes days to weeks of polyuria with adequate fluid intake</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Altered level of consciousness (lethargy to coma)</li>
<li>Neurological deficits: motor and sensory impairment, seizures</li>
<li>Dehydration: dry skin and mucous membranes, extreme thirst, tachycardia, polyuria, hypotension</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hyperglycemia leads to increased urine output and dehydration</li>
<li>Kidneys retain glucose; glucose and sodium rise</li>
<li>Severe hyperosmolar state develops leading to brain cell shrinkage</li>
<li>Diagnostic findings:</li>
<li>The blood glucose level is usually 600 to 1,200 mg/dL (33.33mmol/l - 66.66mmol/l)</li>
<li>Plasma osmolarity 340 mOsm/l or greater- normal 280-300mOsm/l</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emergency-management">Emergency management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emergency-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Similar to that of DKA: fluid replacement, correction of electrolyte imbalances, and insulin administration.</li>
<li>Patient is admitted to ICU and the following treatment initiated</li>
</ul>
<ol>
<li>Insulin is usually administered at a continuous slow rate of 0.1 units/kg/hr to treat hyperglycemia</li>
</ol>
<p>Fluid treatment is started with</p>
<ol start="2">
<li>0.9% or 0.45% NS, depending on the patient's sodium level and the severity of volume depletion</li>
</ol>
<p>cont</p>
<ol start="3">
<li>Potassium is added to IV fluids when urinary output is adequate and is guided by continuous electrocardiographic monitoring and frequent laboratory determinations of potassium.</li>
</ol>
<ul>
<li>Close monitoring of vital signs, fluid status, and laboratory values of electrolytes, blood gases and blood sugars.</li>
</ul>
<p>Comparison of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dka">DKA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dka" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Can occur in type 1 or type 2 diabetes; more common in type 1</li>
<li>Plasma bicarbonate level
&lt;15 mEq/L
Others????</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="long-term-complications">LONG TERM COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#long-term-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Chronic diabetic complications are grouped into three groups:</li>
</ul>
<ol>
<li>Macrovascular complications</li>
<li>Micro vascular complications, and</li>
<li>Neuropathies</li>
</ol>
<ul>
<li>Micro vascular disease is due to damage to small blood vessels and macro vascular disease is due to damage to medium and large blood vessels.</li>
</ul>
<p>cont</p>
<ul>
<li>Chronic elevation of blood glucose level leads to damage of blood vessels (angiopathy).</li>
<li>The endothelial cells lining the blood vessels take in more glucose than normal, since they don't depend on insulin.</li>
<li>They then form more surface glycoproteins than normal, and cause the basement membrane to grow thicker and weaker</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="macrovascular-complications">MACROVASCULAR COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#macrovascular-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Result from changes in the medium to large blood vessels.</li>
<li>Blood vessel walls thicken, sclerose and become occluded by plaque that adheres to the vessel walls. Eventually, blood flow is blocked.</li>
<li>Coronary artery disease, cerebrovascular disease, and peripheral vascular disease are the three main types of macrovascular complications that occur more frequently in the diabetic population.</li>
</ul>
<p><img src="assets/images/image-20251224-ecc1424d.jpeg" alt="img-19.jpeg"></p>
<p>Plaque with fibrous cap</p>
<p>Cap ruptures</p>
<p><img src="assets/images/image-20251224-c76d5a3f.jpeg" alt="img-20.jpeg"></p>
<p><img src="assets/images/image-20251224-ae367970.jpeg" alt="img-21.jpeg"></p>
<p>Blood clot forms around the rupture, blocking the artery</p>
<p><img src="assets/images/image-20251224-2ad232fc.jpeg" alt="img-22.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microvascular-complications">MICROVASCULAR COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microvascular-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Diabetic microvascular disease is characterized by capillary basement membrane thickening.</li>
<li>The basement membrane surrounds the endothelial cells of the capillary.</li>
<li>Micro-vascular complications include; Retinopathy, Nephropathy, neuropathy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetic-retinopathy">Diabetic retinopathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetic-retinopathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Growth of friable and poor-quality new blood vessels in the retina as well as macular edema (swelling of the macula), which can lead to severe vision loss or blindness.</li>
<li>Retinal damage makes it the most common cause of blindness among non-elderly adults</li>
<li>Characterised by Hemorrhage, swelling, decreased vision</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="stages-of-development-of-retinopathy">Stages of development of retinopathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stages-of-development-of-retinopathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Background stage: asymptomatic retinopathy. Blood vessels within the retina develop microaneurysms that leak fluid, causing swelling and forming deposits (exudates)</p>
</li>
<li>
<p>Pre-proliferative stage: Represents increased destruction of retinal blood vessels.</p>
</li>
<li>
<p>Proliferative stage: Abnormal growth of new blood vessels on the retina. New vessels rupture, bleeding into the vitreous humor and blockage of light.</p>
</li>
</ol>
<p><img src="assets/images/image-20251224-cb0e7109.jpeg" alt="img-23.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetic-nephropathy">Diabetic nephropathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetic-nephropathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: glomerular changes in kidneys of diabetics leading to impaired renal function</p>
<ul>
<li>First indicator: microalbuminuria</li>
<li>Diabetics without treatment go on to develop hypertension, edema, progressive renal insufficiency</li>
<li>In type 1 diabetics, 10 – 15 years</li>
<li>May occur soon after diagnosis with type 2 diabetes since many are undiagnosed for years</li>
<li>Most common cause of end-stage renal failure</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetic-neuropathy">Diabetic Neuropathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetic-neuropathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Diabetic neuropathy refers to a group of diseases that affect all types of nerves, including peripheral (sensorimotor), autonomic, and spinal nerves.</li>
<li>There is demyelinization of the nerves caused by hyperglycemia which disrupts conduction of impulses.</li>
<li>Common types of neuropathies are peripheral and autonomic neuropathies.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sexual-dysfunction">SEXUAL DYSFUNCTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sexual-dysfunction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Impotence (inability of the penis to become rigid and sustain an erection adequate for penetration) occurs with greater frequency in diabetic men than in nondiabetic men of the same age.</li>
<li>Some men with autonomic neuropathy have normal erectile function and can experience orgasm but do not ejaculate.</li>
<li>Retrograde ejaculation occurs: seminal fluid is propelled backward through the posterior urethra and into the urinary bladder</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetic-foot-problem">Diabetic foot problem<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetic-foot-problem" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>People with diabetes are at increased risk of foot ulcers and amputations, which are major causes of morbidity and disability.</li>
</ul>
<p>Most common predisposing factors for ulcers and amputations are:</p>
<ul>
<li>Poor foot hygiene.</li>
<li>Unsuitable or no footwear</li>
<li>Peripheral vascular disease.</li>
<li>Peripheral neuropathy with loss of sensation</li>
<li>Deformities</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cornerstones-of-management-of-foot-problems">Cornerstones of Management of Foot Problems<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cornerstones-of-management-of-foot-problems" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Identification of the foot "at risk"</li>
<li>Regular inspection and examination of the foot at risk.</li>
<li>Education of health workers, people with diabetes and their families.</li>
<li>Appropriate footwear.</li>
<li>Early treatment of non-ulcerative and ulcerative problems</li>
</ul>
<p>How to reduce foot ulceration and amputations</p>
<ul>
<li>Optimize blood glucose, blood pressure and lipid control.</li>
<li>Ensure good nutrition status to promote healing.</li>
<li>Encourage patient to stop tobacco smoking/use.</li>
<li>Perform a detailed foot evaluation at presentation and annually.</li>
<li>People with demonstrated risk factors should be examined every 6 months.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examination-of-the-foot">Examination of the foot<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examination-of-the-foot" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>ASK FOR: Symptoms of neuropathy (numbness, tingling or pain) peripheral vascular disease (pain in calves on exercise and at rest)</li>
<li>EXAMINE SKIN: Inspect for ulcers, cracking, fragility, dryness, interdigital laceration and nail pathology</li>
<li>VASCULAR: Skin color, foot and ankle pulses</li>
</ul>
<p>cont</p>
<ul>
<li>BONES/JOINTS: examine for deformities, e.g. claw toes and hammer toes.</li>
<li>FOOTWEAR: check footwear and socks both inside and outside</li>
<li>NEUROPATHY: check protective sensation using 10 g monofilament</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="somogyi-effect">Somogyi effect<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#somogyi-effect" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Combination of hypoglycemia during night with a rebound morning hyperglycemia that may lead to insulin resistance for 12 to 48 hours</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-complication-of-diabetes">OTHER COMPLICATION OF DIABETES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-complication-of-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Infections: patient become susceptible to infections.</p>
<p><img src="assets/images/image-20251224-d514aa88.jpeg" alt="img-24.jpeg"></p>
<p>CHANGINGlife
WITHDIABETES</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="foot-care-for-people-with-diabetes">Foot Care for People with Diabetes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#foot-care-for-people-with-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>People with diabetes have to take special care of their feet. You should have a comprehensive foot exam every year. This page shows some more things you can do to keep your feet healthy.</p>
<p><img src="assets/images/image-20251224-038265b7.jpeg" alt="img-25.jpeg"></p>
<p>Wash your feet in warm water every day.</p>
<p><img src="assets/images/image-20251224-5cd2299c.jpeg" alt="img-26.jpeg"></p>
<p>Dry your feet well, especially between the toes.</p>
<p><img src="assets/images/image-20251224-033fdd31.jpeg" alt="img-27.jpeg"></p>
<p>Keep the skin soft with a moisturizing lotion, but do not apply it between the toes.</p>
<p><img src="assets/images/image-20251224-d495a61e.jpeg" alt="img-28.jpeg"></p>
<p>Inspect your feet every day for cuts, bruises, blisters, or swelling. Tell your doctor right away if you find something wrong.</p>
<p><img src="assets/images/image-20251224-f230e28b.jpeg" alt="img-29.jpeg"></p>
<p>Ask your diabetes care team how you should care for your toenails.</p>
<p><img src="assets/images/image-20251224-2121596a.jpeg" alt="img-30.jpeg"></p>
<p>Wear clean, soft socks that fit you.</p>
<p><img src="assets/images/image-20251224-c45905be.jpeg" alt="img-31.jpeg"></p>
<p>Keep your feet warm and dry. Always wear shoes that fit well.</p>
<p><img src="assets/images/image-20251224-f42b0762.jpeg" alt="img-32.jpeg"></p>
<p>Never walk barefoot indoors or outdoors.</p>
<p><img src="assets/images/image-20251224-a24dcf7d.jpeg" alt="img-33.jpeg"></p>
<p>Examine your shoes every day for cracks, pebbles, nails, or anything that could hurt your feet.</p>
<p><strong>Take good care of your feet – and use them. A brisk walk every day is good for you.</strong></p>
<p>For more information, call the Novo Nordisk Diabetes Tip Line at 1-800-260-3730, or visit us online at ChangingDiabetes-us.com.</p>
<p><img src="assets/images/image-20251224-4473b8f5.jpeg" alt="img-34.jpeg"></p>
<table><thead><tr><th></th><th></th><th></th></tr></thead></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="common-areas-of-irritation-ulcers-diabetic-foot">Common areas of Irritation/Ulcers - Diabetic Foot<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-areas-of-irritation-ulcers-diabetic-foot" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-7a5bb002.jpeg" alt="img-35.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="somogyi-effect">Somogyi effect<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#somogyi-effect" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Combination of hypoglycemia during night with a rebound morning hyperglycemia that may lead to insulin resistance for 12 to 48 hours</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-complication-of-diabetes">OTHER COMPLICATION OF DIABETES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-complication-of-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Infections: patient become susceptible to infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pituitary-gland">PITUITARY GLAND<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pituitary-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disorders">DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pituitary-gland-disorders">PITUITARY GLAND DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pituitary-gland-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Abnormalities of pituitary function are caused by oversecretion or undersecretion of any of the hormones produced or released by the gland.</li>
<li>Oversecretion (hypersecretion) most commonly involves ACTH or growth hormone</li>
<li>Oversecretion of ACTH results in cushing’s syndrome</li>
<li>Oversecretion of growth results in acromegaly in adults :</li>
<li>acromegaly results in bone and soft tissue deformities and enlargement of the viscera without an increase in height.</li>
</ul>
<p>cont</p>
<ul>
<li>Oversecretion of growth hormone in children results in gigantism</li>
<li>In insufficient secretion of growth hormone during childhood results in generalized limited growth and dwarfism</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hypopituitarism">HYPOPITUITARISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypopituitarism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Refers to hypofunctioning or hyposecretion of pituitary hormones.</p>
</li>
<li>
<p>Result from disease of the pituitary gland itself or of the hypothalamus</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes-of-hyposecretion-of-pituitary-hormones">Causes of hyposecretion of pituitary hormones<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-hyposecretion-of-pituitary-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>radiation therapy to the head and neck area.</li>
<li>Trauma to the pituitary glands</li>
<li>Pituitary tumors</li>
<li>Vascular lesion in the pituitary gland</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperpituitarism">Hyperpituitarism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperpituitarism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Results in excess production and secretion of one or more hormones such as GH, PRL, ACTH.</li>
<li>Most common cause is a benign adenoma</li>
<li>Anterior pituitary adenoma,</li>
<li>a benign tumor.</li>
<li>Prolactin and GH are the hormones most commonly over-produced by adenomas.</li>
</ul>
<p>The Pituitary &amp; Hypothalamus</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="changes-in-neurological-function-may-occur-as-adenomas-compress-surrounding-tissue">Changes in neurological function may occur as adenomas compress surrounding tissue.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#changes-in-neurological-function-may-occur-as-adenomas-compress-surrounding-tissue" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Manifestations include headaches, visual defects and increased ICP (intracranial pressure)</p>
<p>Treatment is surgical resection through</p>
<p><img src="assets/images/image-20251224-0dfb233b.jpeg" alt="img-36.jpeg"></p>
<p><img src="assets/images/image-20251224-83c0ae4d.jpeg" alt="img-37.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="increased-gh">Increased GH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#increased-gh" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Increased GH: <strong>Gigantism &amp; Acromegaly</strong></li>
<li>a statue of Robert Wadlow, the "Alton Giant," who measured 8 feet 11 inches at the time of his death.</li>
<li>Young 12 y/o male standing with his mother</li>
</ul>
<p><img src="assets/images/image-20251224-2c154d9e.jpeg" alt="img-38.jpeg"></p>
<p><img src="assets/images/image-20251224-c49dff32.jpeg" alt="img-39.jpeg"></p>
<ul>
<li>
<p>Gigantism is the result of GH hypersecretion before the closure of the epiphyseal plates (childhood).</p>
</li>
<li>
<p>Abnormally tall but body proportions are normal</p>
</li>
<li>
<p>Acromegaly is over secretion of GH in adulthood</p>
</li>
<li>
<p>Continued growth of boney, connective tissue leads to disproportionate enlargement of tissue..</p>
</li>
</ul>
<p><img src="assets/images/image-20251224-26589528.jpeg" alt="img-40.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acromegaly">Acromegaly<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acromegaly" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Rare condition – develops between ages 30-50</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="symptoms">Symptoms:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Coarsening of facial features</li>
<li>Enlarged hands &amp; feet</li>
<li>Carpel trunnel syndrome</li>
<li>Excessive sweating &amp; oily skin</li>
<li>Headaches</li>
<li>Vision disturbance</li>
<li>Sleep apnea</li>
<li>General tiredness</li>
<li>Oligomenorrhea or amenorrhea</li>
<li>Impotence (adult males)</li>
<li>Decreased libido</li>
</ul>
<p>Copyright EndoPics, Imperial College, London</p>
<p><img src="assets/images/image-20251224-6c0fa05d.jpeg" alt="img-41.jpeg"></p>
<p><img src="assets/images/image-20251224-35653062.jpeg" alt="img-42.jpeg"></p>
<p><img src="assets/images/image-20251224-f8550c8d.jpeg" alt="img-43.jpeg">
Normal lower jaw</p>
<p><img src="assets/images/image-20251224-c2729468.jpeg" alt="img-44.jpeg"></p>
<p><img src="assets/images/image-20251224-8873f901.jpeg" alt="img-45.jpeg">
Prognathic lower jaw</p>
<p><img src="assets/images/image-20251224-f9f83575.jpeg" alt="img-46.jpeg"></p>
<p>ADAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnosis">Diagnosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>History &amp; physical exam</li>
<li>Investigation includes:</li>
<li>GH analysis (glucose tolerance) Normally GH concentration falls with oral glucose; in acromegaly it does not.</li>
<li>Prolactin levels as well as other pituitary function tests</li>
<li>MRI or CT &amp; visual field tests to determine size and position of the adenoma.</li>
<li>Bone scan</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="treatment">Treatment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Surgery (primary choice)</li>
<li>Radiotherapy</li>
<li>Drug treatment – when surgery is not feasible</li>
<li>Combinations of above</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-treatment-of-acromegaly">Drug treatment of Acromegaly<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-treatment-of-acromegaly" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Dopamine agonists: Dopamine agonists work to inhibit GH release from the tumour</li>
<li>Somatostatin: growth hormone receptor antagonist decreases the action of GH on target tissues</li>
<li>Dopamine agonists are taken by mouth but in generally are less effective than somatostatin analogues, which have to be injected.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anterior-pituitary-disorders">Anterior Pituitary Disorders<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anterior-pituitary-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Hormone</th><th>Increased level</th><th>Decreased level</th></tr></thead><tbody><tr><td>GH</td><td>Gigantism (child)</td><td></td></tr><tr><td>Acromegaly (adult)</td><td>Dwarfism (child)</td><td></td></tr><tr><td>Lethargy, premature aging</td><td></td><td></td></tr><tr><td>ACTH</td><td>Cushing’s Disease</td><td>Addison’s Disease</td></tr><tr><td>TSH</td><td>Goiter, increased BMR, HR, BP</td><td></td></tr><tr><td>Graves disease</td><td>Decreased BMR, HR, CO, BP</td><td></td></tr><tr><td>Cretinism (children)</td><td></td><td></td></tr><tr><td>Prolactin</td><td>amenorrhea</td><td>Too little milk</td></tr><tr><td>FSH</td><td></td><td>Late puberty, infertility</td></tr><tr><td>LH</td><td>Menstrual cycle disturbance</td><td>Amenorrhea, impotence</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="posterior-pituitary-disorders">Posterior Pituitary Disorders<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#posterior-pituitary-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Hormone</th><th>Increased</th><th>Decreased</th></tr></thead><tbody><tr><td>Oxytocin</td><td>Precipitates childbirth, excess milk</td><td>Prolonged childbirth, diminished milk</td></tr><tr><td>ADH (vassopressin)</td><td>Increased BP, decreased urinary output, edema. SIADH</td><td>Diabetes insipidus, dilute urine &amp; increased urine output</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dac08bb">Hyper – Posterior Pituitary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dac08bb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="siadh">SIADH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#siadh" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Syndrome of Inappropriate Anti-Diuretic Hormone</li>
<li>Too much ADH produced or secreted.</li>
<li>SIADH commonly results from malignancies, CHF, &amp; CVA - resulting in damage to the hypothalamus or pituitary which causes failure of the feedback loop that regulates ADH.</li>
<li>Client retains water causing dilutional hyponaetremia &amp; decreased osmolality.</li>
<li>Decreased serum osmolality cause water to move into cells</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="signs-and-symptoms">Signs and Symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Lethargy &amp; weakness</li>
<li>Confusion or changes in neurological status</li>
<li>Cerebral edema</li>
<li>Muscle cramps</li>
<li>Decreased urine output</li>
<li>Weight gain without edema</li>
<li>Hypertension</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment">Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Serum sodium low</li>
<li>Serum osmolality low</li>
<li>Urine osmolality disproportionately elevated in relation to the serum osmolality</li>
<li>Urine specific gravity elevated</li>
<li>Plasma ADH elevated</li>
</ul>
<p>Water intoxication, cerebral edema, severe hyponatremia cause altered neurological status, which untreated may cause death</p>
<p><img src="assets/images/image-20251224-3c30bde7.jpeg" alt="img-47.jpeg"></p>
<p>!!!!!!</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="treatment-of-siadh">Treatment of SIADH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment-of-siadh" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Treat underlying cause</li>
<li>Hypertonic or isotonic IV solution</li>
<li>Monitor for signs of fluid and electrolyte imbalance</li>
<li>Monitor for neurological effects</li>
<li>Monitor in and out</li>
<li>Weigh</li>
<li>Restrict fluid intake</li>
<li>Medic Alert</li>
<li>Lithium inhibits action of ADH to promote water excretion.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2d975d7c">Hypofunction – Posterior pituitary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2d975d7c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="normal-urine-production">Normal urine production<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#normal-urine-production" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-a5eeb768.jpeg" alt="img-48.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diabetes-insipitus-di">Diabetes Insipitus (DI)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diabetes-insipitus-di" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>DI is usually insidious but can occur with damage to the hypothalamus or the pituitary. (neurogenic DI)</li>
<li>May be a result of defect in renal tubules, do not respond to ADH (nephrogenic DI)</li>
<li>Decreased production or release of ADH results in massive water loss</li>
<li>Leads to hypovolemic &amp; dehydration</li>
</ul>
<p><img src="assets/images/image-20251224-99d9de02.jpeg" alt="img-49.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnostic-tests">Diagnostic Tests<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnostic-tests" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Serum sodium</li>
<li>Urine specific gravity</li>
<li>Serum osmolality</li>
<li>Urine osmolality</li>
<li>Serum ADH levels</li>
<li>Vasopressin test and water deprivation test: increased hyperosmolality is diagnostic for DI.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management">Management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Medical management includes</li>
<li>Rehydration IV fluids (hypotonic)</li>
<li>Symptom management</li>
<li>ADH replacement (vasopressin)</li>
<li>For nephrogenic DI: thiazide diuretics, mild salt depletion, prostaglandin inhibitors (i.e. ibuprophen)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing">Nursing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Monitor for signs of fluid and electrolyte imbalance</li>
<li>Monitor in and out</li>
<li>Daily weight</li>
<li>Monitor for excessive thirst or output</li>
<li>Assess serum and urine values (decreased SG, decreased urine osmolality, high serum osmolality are early indicators)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="possible-nursing-diagnosis">POSSIBLE NURSING DIAGNOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#possible-nursing-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Fluid Volume Deficit</li>
<li>Risk for Injury r/t altered LOC</li>
<li>Risk for Altered Health Maintenance</li>
<li>Sleep Pattern Disturbance r/t urinary frequency or anxiety</li>
<li>Altered Urinary Elimination r/t excess urinary output</li>
<li>Body Image</li>
<li>Altered sexuality</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="panhypopituitarism">Panhypopituitarism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#panhypopituitarism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>When both the anterior and posterior fail to secrete hormones, the condition is called panhypopituitarism.</li>
<li>Causes include tumors, infection, injury, iatrogenic (radiation, surgery), infarction</li>
<li>Manifestations don’t occur until 75% of pituitary has been obliterated.</li>
<li>Treatment involves removal of cause and hormone replacement (adrenocortical insufficiency, thyroid hormone, sex hormones)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disorders-of-thyroid-gland">DISORDERS OF THYROID GLAND<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders-of-thyroid-gland" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>HYPOTHYROIDISM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hypothyroidism">HYPOTHYROIDISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypothyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Def: refers to hyposecretion of thyroid hormones specifically T3 and T4.</li>
<li>It is also referred to as thyroid deficiency. Thyroid deficiency affect all body functions</li>
<li>When thyroid deficiency is present at birth, the condition is known as cretinism.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">CAUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Autoimmune thyroiditis (Hashimoto’s disease), in which the immune system attacks the thyroid gland.</li>
</ol>
<ul>
<li>It is the most common cause.</li>
</ul>
<p>cont</p>
<ul>
<li>Atrophy of thyroid gland with aging</li>
<li>Radioactive iodine</li>
<li>Thyroidectomy</li>
<li>Medications like Lithium and Antithyroid medications</li>
<li>Radiation to head and neck for treatment of head and neck</li>
<li>cancers, lymphoma</li>
<li>Infiltrative diseases of the thyroid (amyloidosis, scleroderma)</li>
<li>Iodine deficiency and iodine excess</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="predisposing-factors">PREDISPOSING FACTORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#predisposing-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Previous treatment with antithyroid medications and radioactive iodine</li>
<li>Thyroidectomy</li>
<li>Advance age; common in older women</li>
<li>Radiation therapy for head and neck for cancer</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">PATHOPHYSIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hypothyroidism can be caused by thyroid dysfunction itself or pituitary gland and hypothalamus.</li>
<li>In both, there is hyposecretion of T3 and T4 hormones which leads to decreased basal metabolic rate characterized by lethargy, fatigue, cold intolerance, weight gain and constipation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Extreme fatigue</p>
</li>
<li>
<p>hair loss, brittle nails, and dry skin</p>
</li>
<li>
<p>numbness and tingling of the Fingers</p>
</li>
<li>
<p>Cold intolerance</p>
</li>
<li>
<p>Weight gain</p>
</li>
<li>
<p>constipation</p>
</li>
<li>
<p>Forgetfullness</p>
</li>
<li>
<p>Menstrual disturbances such as menorrhagia or amenorrhea</p>
</li>
<li>
<p>Slowness of movement</p>
</li>
<li>
<p>Bradycardia</p>
</li>
<li>
<p>irritability</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hormone replacement therapy: synthetic levothyroxine is administered.</li>
<li>BRAND NAME: Synthroid, levoxyl, levothroid and unithroid</li>
<li>Is a drug of choice for most patients who need thyroid hormone replacement.</li>
</ul>
<p>MODE OF ACTION: It increases metabolic rate of all cells of all tissues in the body</p>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacokinetics">PHARMACOKINETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Most of it converted into T3 in the body hence can produce both T3 and T4</li>
<li>highly bound to proteins and has a half life of 7 days hence it therapeutic effects are delayed for 2 weeks</li>
<li>The long half life facilitate once a day dosing</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses-indications">THERAPEUTIC USES (INDICATIONS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses-indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Indicated in hypothyroidism in adult and children</li>
<li>Maintenance of thyroid hormones following surgery</li>
<li>Myxedema coma</li>
<li>Simple goiter.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dosage-and-administration">Dosage and administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage-and-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Starting dosage is 12.5mcg/day orally.</li>
<li>Dosage changes may differ with individual patients based upon age, the presence of cardiovascular disease and development of tolerance or reduced effectiveness of drug</li>
<li>The drug is available in tablet forms, capsules and IV.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-interactions">Drug interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Increases the need of insulin in diabetic patients</li>
<li>Increases the effects of warfarin therefore monitoring of blood clotting is necessary</li>
<li>Increases cardiac response to catecholamines (epinephrine) thereby increasing the risk of catecholamine induced dysrhythmias.</li>
<li>Caution must be exercised when administering catecholamines to patients using the drug</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="duration-of-therapy">DURATION OF THERAPY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#duration-of-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Replacement therapy must be continued for life.</li>
<li>The patient must be made fully aware of the chronic nature of the condition</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management-of-hypothyroidism">Nursing management of hypothyroidism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management-of-hypothyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Promote independence in self-care
Activities by:
a. Spacing activities to promote rest and exercise as tolerated.
b. Assisting with self-care activities when patient is fatigued.
c. Monitor patient’s response to increasing activities.</li>
</ol>
<p>cont</p>
<ol start="2">
<li>Provide extra layer of clothing or extra blanket to minimize heat loss</li>
<li>Avoid and discourage use of external heat source (eg, heating pads, electric or warming blankets). It reduces the risk of peripheral vasodilation and vascular collapse</li>
<li>Encourage increased fluid intake within limits of fluid restriction. It promotes passage of soft stool</li>
</ol>
<p>cont</p>
<ol start="5">
<li>
<p>Administer hormone replacement: usually Levothyroxine(Synthroid)-should be taken on an empty stomach 30-60 min before eating...in the morning... food, iron and calcium..may reduce its absorption in the gut.</p>
</li>
<li>
<p>Provide foods with low calories and high in fiber. It increases bulk of stools and more frequent bowel movements.</p>
</li>
<li>
<p>Monitor patient's vitals signs esp body temperature and report decreases from patient's baseline value.</p>
</li>
</ol>
<p>Monitoring detects decreased body temperature and onset of myxedema coma baseline value.</p>
<p>cont</p>
<ol start="8">
<li>Health education : Explain rationale for thyroid hormone replacement</li>
<li>Advise to report palpitation, tachycardia, and chest pain when using levothyroxine</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="myxedema">MYXEDEMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#myxedema" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Def: myxedema refers to the accumulation of mucopolysaccharides in subcutaneous and other interstitial tissues. There is thickening of skin with non pitting edema</li>
<li>Occurs in long-standing hypothyroidism. The term is used appropriately only to describe the extreme symptoms of severe hypothyroidism.</li>
<li>It presents with symptoms of hypothyroidism plus extreme hypothermia with personality and cognitive changes characteristic of dementia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management">management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hormone replacement therapy using levothyroxine</li>
<li>Treatment the underlying cause of hypothyroidism</li>
<li>Nursing management same as those of hypothyroidism</li>
<li>The patient is sensitive to sedatives, opioids, and anesthetic agents. Therefore, these medications are administered only with extreme caution.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="myxedema-coma">Myxedema coma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#myxedema-coma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Myxedema coma describes the most extreme, severe stage of hypothyroidism, in which the patient is hypothermic and unconscious.</li>
<li>It is a life threatening condition and it is regarded as a medical emergency.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="presenting-features">PRESENTING FEATURES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#presenting-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Severe hypothermia</li>
<li>Depressed respirations</li>
<li>Coma</li>
<li>Cool clummy skin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emergency-management">Emergency management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emergency-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Admit the patient into the ICU</li>
<li>IV levothyroxine is administered until consciousness is restored. The patient is then continued on oral thyroid hormone therapy</li>
<li>Arterial blood gases are measured to determine CO2 retention and to guide the use of assisted ventilation to combat hypoventilation</li>
<li>Provide warmth to the patient by covering with enough blankets</li>
<li>Fluids are administered cautiously because of the danger of water intoxication</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="caution-when-administering-iv-levothyroxine-in-myxedema-coma">Caution when administering iv levothyroxine in myxedema coma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#caution-when-administering-iv-levothyroxine-in-myxedema-coma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>monitor for myocardial ischemia or infarction, which may occur in response to therapy</li>
<li>The nurse must also be alert for signs of angina, especially during the early phase of treatment; if detected, it must be reported and treated at once to avoid a fatal myocardial infarction</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management">Nursing management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administer prescribed medications (eg, levothyroxine) with extreme caution because the slow metabolism and atherosclerosis of Myxedema may result in angina with administration of levothyroxine</li>
<li>Assist in Ventilatory support: is necessary to maintain adequate oxygenation and maintenance of an airway.</li>
<li>Turn and reposition patient at interval. Minimizes risks associated with immobility</li>
<li>Monitor patients respiratory status.</li>
<li>Apply other nursing interventions of hypothyroidism</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="levothyroxine">Levothyroxine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#levothyroxine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>50 micrograms Tablets
Levothyroxine Sodium</p>
<p>28 Tablets</p>
<p><img src="assets/images/image-20251224-404dff84.jpeg" alt="img-50.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperthyroidism">HYPERTHYROIDISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperthyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Def: Hyperthyroid state characterized by increased circulating T3 and T4</li>
<li>There is oversecretion of thyroid hormones by the thyroid gland.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="prevalence">PREVALENCE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#prevalence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It affects women eight times more frequently than men, with onset usually between the second and fourth decades</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Overstimulation of thyroid gland by immunoglobulins</li>
<li>Thyroiditis</li>
<li>Excessive ingestion of thyroid hormone.</li>
<li>Tumors of thyroid gland or pituitary gland</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="forms-of-hyperthyroidism">FORMS OF HYPERTHYROIDISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#forms-of-hyperthyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Graves disease: the most common type of hyperthyroidism, results from an excessive output of thyroid hormones caused by abnormal stimulation of the thyroid gland by circulating immunoglobulins.</li>
</ol>
<ul>
<li>Also called Toxic goiters: causes overstimulation of thyroid gland.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hyperthyroidism may occur with the release of excessive amounts of thyroid hormone as a result of inflammation after irradiation of the thyroid or destruction of thyroid tissue by tumor.</li>
<li>Excessive hormones leads to increased hormone activity which leads to increased Basal Metabolism and cardiac activity</li>
<li>Increased metabolism is characterised by increased appetite and dietary intake, progressive weight loss, abnormal muscular fatigability and weakness</li>
<li>The patients exhibits a group of sign and symptoms (sometimes called thyrotoxicosis)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Weight loss</li>
<li>HEAT intolerance</li>
<li>Hypertension</li>
<li>Tachycardia and palpitations and increased pulse pressure</li>
</ol>
<ul>
<li>Fast Pulse rate btw 90-160</li>
</ul>
<ol start="5">
<li>
<p>Exophthalmos (bulging eyes) with startled facial expression</p>
</li>
<li>
<p>Diarrhea</p>
</li>
<li>
<p>flushed skin : warm, soft, and moist</p>
</li>
<li>
<p>Oligomenorrhea to amenorrhea</p>
</li>
<li>
<p>Fine tremors and nervousness and clubbing</p>
</li>
<li>
<p>Irritability, mood swings, personality changes and agitation</p>
</li>
<li>
<p>Enlarged thyroid</p>
</li>
<li>
<p>Osteoporosis and fractures</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperthyroidism">HYPERTHYROIDISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperthyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-6729ca2f.jpeg" alt="img-51.jpeg"></p>
<p>©2007 Nursing Education Consultants, Inc.</p>
<table><thead><tr><th></th><th></th><th></th></tr></thead></table>
<p><img src="assets/images/image-20251224-3b9e241b.jpeg" alt="img-52.jpeg">
A</p>
<p><img src="assets/images/image-20251224-16424569.jpeg" alt="img-53.jpeg">
B</p>
<p>Assessment findings</p>
<ul>
<li>Client has heat intolerance and may have diaphoresis (increased sweating) even when environmental temperatures are comfortable for others.</li>
<li>Client report palpitations or chest pain</li>
<li>Client experiences emotional lability ( mood instability ), irritability, decreased attention span and manic behaviour.</li>
<li>Fatigue, weakness and insomnia</li>
<li>The thyroid gland invariably is enlarged to some extent. It is soft and may pulsate</li>
<li>Increased serum levels of T4 and iodine intake by the thyroid gland</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Can be managed by:</p>
<ol>
<li>Pharmacological therapy</li>
<li>Surgical therapy</li>
</ol>
<p>PHARMACOLOGICAL THERAPY</p>
<p>(1) use of irradiation by administration of the radioisotope 121I or 131I for destructive effects on the thyroid gland
(2) antithyroid medications that interfere with the synthesis of thyroid hormones</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antithyroid-medications">Antithyroid medications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antithyroid-medications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Include ; propylthiouracil , carbimazole.</p>
<ol>
<li>PROPYLTHIOURACIL propacil( PTU)</li>
</ol>
<p>(A) Mechanism of action : inhibit thyroid hormone synthesis by inhibiting incorporation of iodine into tyrosine. It also suppress conversion of T4 into T3 the more active form of thyroid hormone.</p>
<p>(B) Pharmacokinetics</p>
<ul>
<li>
<p>is rapidly absorbed following oral administration</p>
</li>
<li>
<p>Therapeutic effects begin after 30 mins</p>
</li>
<li>
<p>The plasma half-life is short(2hrs).</p>
</li>
</ul>
<p>As a result ,it is administered three times a day</p>
<p>cont</p>
<p>(c) therapeutic uses /indications</p>
<ul>
<li>Hyperthyroidism</li>
<li>Adjunct to radiation therapy. Used to control hyperthyroidism until effects of radiation become manifest.</li>
<li>Thyrotoxic crisis, (thyroid storm)</li>
</ul>
<p>(d) ADVERSE EFFECTS</p>
<ol>
<li>hypothyroidism; excessive dosing with PTU may lead to hypothyroidism</li>
</ol>
<p>cont</p>
<ol start="2">
<li>
<p>agranulocytosis; severe bone marrow depression. Resulting in failure to produce neutrophils. Usually occurs during the first 2 months of life. sore throat and fever are the earliest indications. Patients are instructed to report these immediately. The drug is stopped immediately if the symptom S/E develops.</p>
</li>
<li>
<p>skin rashes, headaches, nausea and joint pains</p>
</li>
</ol>
<p>cont</p>
<p>DOSAGE : Propylthiouracil-100-150mg every 6 or 8 hrs</p>
<p>DURATION : 18-24 months</p>
<p><strong>PTU AND PREGNANCY</strong></p>
<ul>
<li>
<p>PTU crosses placenta</p>
</li>
<li>
<p>Propylthiouracil is preferred over carbimazole in pregnant women because its rapid action reduces transfer across the placental barrier and it doesn't cause aplasia cutis (a severe skin disorder) in the fetus</p>
</li>
</ul>
<p>cont</p>
<ul>
<li>Mothers taking these drugs shouldn’t breast-feed.</li>
<li>If a breast-feeding woman must take one of these drugs, propylthiouracil is the preferred drug.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="carbimazole">CARBIMAZOLE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#carbimazole" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Mechanism of action: decreases uptake iodine needed in formation of thyroxine and incorporation of iodine into tyrosine to form thyroxine</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dosage">Dosage<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The initial dose is 15-40 mg daily given for 4 to 8 weeks until euthyroid status is achieved.</li>
<li>The dose is gradually reduced to a maintenance of 5-15 mg daily.</li>
<li>Treatment is usually required for 12-18 months</li>
<li>Patients should have their T4 levels checked every 4-6 weeks</li>
</ul>
<p>Cont</p>
<ul>
<li>Once maintenance dose has been established, T4 and TSH should be checked every 3 months.</li>
<li>Patients should be regularly reviewed during the first year after discontinuing carbimazole because there is high rate of relapse during this period.</li>
<li>Carbimazole is used at the lowest dose possible in pregnancy however PTU is preferred over carbimazole</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="radioactive-iodine-therapy">Radioactive iodine therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#radioactive-iodine-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Is used as a radiation therapy</p>
</li>
<li>
<p>Used to destroy thyroid tissue in patients with hyperthyroidism</p>
</li>
<li>
<p>Mechanism of action: produce emission of beta particles that destroy thyroid tissue.</p>
</li>
<li>
<p>Reduction of thyroid tissue is gradual and effects takes weeks to become apparent</p>
</li>
<li>
<p>A single oral dose of the agent is administered</p>
</li>
<li>
<p>Is used as a radiation therapy</p>
</li>
<li>
<p>Used to destroy thyroid tissue in patients with hyperthyroidism</p>
</li>
<li>
<p>Mechanism of action: produce emission of beta particles that destroy thyroid tissue.</p>
</li>
<li>
<p>Reduction of thyroid tissue is gradual and effects takes weeks to become apparent</p>
</li>
</ul>
<p>cont</p>
<ul>
<li>Almost all the iodine that enters and is retained in the body becomes concentrated in the thyroid gland.</li>
<li>Radioactive isotope of iodine is concentrated in the thyroid gland, where it destroys thyroid cells without jeopardizing other radiosensitive tissues.</li>
</ul>
<p>NB: Antithyroid medications are contraindicated in late pregnancy because they may produce goiter and cretinism in the fetus</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adjunctive-therapy">Adjunctive Therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adjunctive-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Beta-adrenergic blocking agents are important in controlling the sympathetic nervous system effects of hyperthyroidism.</li>
<li>Propranolol (Inderal) is used to control nervousness, tachycardia, tremor, anxiety and heat intolerance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management">Nursing management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Provide adequate rest periods in a quiet room because fatigue is common</li>
<li>Administer anti-thyroid medications that block hormone synthesis- carbimazole and PTU and monitor for side effects</li>
<li>Provide a high-calorie diet, high protein to provide energy and build the body</li>
<li>Provide a cool and quiet environment to reduce irritability. Noises, such as loud music, conversation, and equipment alarms, are minimized.</li>
</ol>
<p>cont</p>
<ol start="5">
<li>
<p>Maintain the environment at a cool, comfortable temperature and change beddings and clothing as needed. Cool baths and cool or cold fluids may provide relief.</p>
</li>
<li>
<p>Assesses and monitor the patient's cardiac status, including heart rate, blood pressure, heart sounds, and peripheral pulses</p>
</li>
<li>
<p>To reduce diarrhea, highly seasoned foods and stimulants such as coffee, tea, cola, and alcohol are discouraged. In addition, fluids are added as needed</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="thyroid-storm-thyrotoxic-crisis-thyrotoxicosis">Thyroid Storm (Thyrotoxic Crisis, Thyrotoxicosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thyroid-storm-thyrotoxic-crisis-thyrotoxicosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>An acute LIFE-threatening condition characterized by excessive thyroid hormone</li>
<li>Is the most severe form of hyperthyroidism with acute onset.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical Manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Thyroid storm is characterized by:</p>
<ol>
<li>High fever (hyperpyrexia) above 38.5°C (101.3°F)</li>
<li>Extreme tachycardia (more than 130 beats/min)</li>
<li>Severe weight loss, diarrhea, abdominal pain</li>
<li>dyspnea</li>
<li>Altered neurologic or mental state, which frequently appears as delirium, psychosis, or coma</li>
<li>Restlessness, Agitation, confusion and Seizures</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="precipitating-factors">Precipitating factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#precipitating-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Injury on the body</li>
<li>Systemic infection</li>
<li>Thyroid and non thyroid surgery</li>
<li>Tooth extraction</li>
<li>Insulin reaction</li>
<li>Diabetic acidosis</li>
<li>Pregnancy</li>
<li>Digitalis intoxication,</li>
<li>abrupt withdrawal of antithyroid medications,</li>
<li>Extreme emotional stress</li>
<li>Vigorous palpation of the thyroid.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emergency-management">EMERGENCY MANAGEMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emergency-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Humidified oxygen is administered to improve tissue oxygenation and meet the high metabolic demands</li>
<li>Arterial blood gas levels or pulse oximetry may be used to monitor respiratory status.</li>
<li>Intravenous fluids containing dextrose are administered to replace liver glycogen stores that have been decreased in the hyperthyroid patient.</li>
<li>PTU or Carbimazole is administered to impede formation of thyroid hormone and block conversion of T4 to T3, the more active form of thyroid hormone.</li>
<li>Hydrocortisone is prescribed to treat shock or adrenal insufficiency.</li>
</ul>
<p>cont</p>
<ul>
<li>Cool environment and acetaminophen (Tylenol) to reduce fever. Salicylates (eg, aspirin) are not used because they displace thyroid hormone from binding proteins and worsen the hypermetabolism</li>
<li>Propranolol, combined with digitalis, are administered to reduce severe cardiac symptoms</li>
<li>Iodine is administered to decrease output of T4 from the thyroid gland</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-interventions">Nursing interventions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-interventions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Maintain PATENT airway and adequate ventilation. Oxygen is needed to meet metabolic demands</li>
<li>Administer anti-thyroid drugs with medications such as
(a) Lugol's solution: consist of 5% Iodide and 10% potassium... blocks peripheral conversion of T4 to T3 hence inhibiting hormone release.
(b) Propranolol: is a beta blockers to reduce cardiac heart rate.
(c) Glucocorticoids: inhibit hormone production and decrease peripheral conversion from T4 to T3.</li>
</ol>
<p>cont</p>
<ol start="3">
<li>Monitor VS including pulse rate and temperature</li>
<li>Monitor Cardiac rhythms</li>
<li>Provide a quiet environment</li>
<li>Administer antipyretics like paracetamol</li>
<li>Administer IV fluids to correct dehydration</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="goitre">GOITRE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goitre" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Abnormal enlargement of thyroid gland due to inflammation or tumor that become visible</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mortality-and-morbidity">Mortality and Morbidity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mortality-and-morbidity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Most goitres are benign, causing only cosmetic disfigurement</p>
</li>
<li>
<p>Morbidity or mortality may result from compression of surrounding structures, thyroid cancer, hyperthyroidism or hypothyroidism</p>
</li>
<li>
<p>Female to male ratio : 4 : 1</p>
</li>
<li>
<p>They are common in women than men</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification-of-goiters">Classification of goiters<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-goiters" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Toxic goiter : a goiter that is associated with hyperthyroidism
Examples include : a. diffuse toxic goiter (graves disease)
b. toxic multinodular goiter and toxic adenoma</p>
</li>
<li>
<p>Non toxic goiter: a goiter without hyperthyroidism or hypothyroidism. Examples are congenital goitre and physiologic goiter that occurs during puberty</p>
</li>
<li>
<p>Non – toxic goiters</p>
</li>
</ol>
<p>There are four types of Non Toxic goiters
a. Diffuse non-toxic goiter
b. Multinodular non-toxic goiter
c. simple goiter
d. uninodular goitre</p>
<p>A. Diffuse non – toxic goiter</p>
<ul>
<li>Develops during early stage of disease</li>
<li>The thyroid gland is diffusely enlarged</li>
<li>There is hypertrophy and hyperplasia of follicular cells.</li>
</ul>
<p>cont</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-multinodular-non-toxic-goiter">B. Multinodular non-toxic goiter<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-multinodular-non-toxic-goiter" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Evolves as the disease becomes chronic</li>
<li>The gland develops nodules that vary in shape</li>
<li>Is the most common especially in older patients.</li>
<li>It's the most common cause of tracheal and oesophageal compression and may cause laryngeal nerve palsy..</li>
</ul>
<p>cont</p>
<p>C. simple goiter - There is no clear cause for enlargement of the thyroid which is usually smooth and soft.</p>
<p>d. Solitary nodular goiter (Plummers syndrome) - They are usually cystic or benign with a history of pain, rapid enlargement or associated lymph nodes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-features-of-non-toxic-goiters">Clinical features of non-toxic goiters<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-features-of-non-toxic-goiters" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Patients are asymptomatic presenting with a mass in the neck</li>
<li>If goiter is large, there will be compressive symptoms such as dysphagia (difficulty in swallowing)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="causes-of-goitres">Causes of goitres<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-goitres" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hypertrophy caused by excess stimulation</li>
<li>Iodine deficiency</li>
<li>Hashimoto's thyroiditis</li>
<li>Goitrogens: are substances that suppress the function of thyroid gland by interfering with iodine uptake e. g cassava and sweet potatoes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology-of-simple-goitre">Pathophysiology of simple goitre<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology-of-simple-goitre" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>simple goiter may be caused by lack of iodine and intake of large quantities of goitrogenic substances</li>
<li>The pituitary gland produces thyrotropin or TSH, a hormone that controls the release of thyroid hormone from the thyroid gland.</li>
<li>Its production increases if there is subnormal thyroid activity, as when insufficient iodine is available for production of the thyroid hormone..</li>
<li>Increase in TSH courses overstimulation of thyroid gland leading to compensatory hypertrophy or enlargement</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="investigations">Investigations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#investigations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Thyroid function tests of thyroid stimulating hormone, thyroxine and triiodothyronine to determine whether a goitre is associated with hyperthyroidism, hypothyroidism or normal thyroid function</li>
<li>Chest and thoracic inlet x-rays to detect tracheal compression.</li>
</ul>
<p>cont</p>
<ul>
<li>Measurement of thyroid antibodies to assess for thyroiditis.</li>
<li>Ultrasound to demonstrate whether the nodules are cystic or solid.</li>
<li>Thyroid scan to determine whether the nodule is malignant.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="treatment">Treatment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A goitre associated with normal thyroid function in pregnancy and puberty rarely requires intervention and patient needs to be reassured</li>
<li>Surgery if there is obstructive symptoms</li>
<li>In older patients Radioactive iodine therapy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications-for-surgery">Indications for surgery<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications-for-surgery" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The possibility of malignancy where there is a history of rapid growth, pain, cervical lymphadenopathy or previous irradiation.</li>
<li>Pressure symptoms on the trachea.</li>
<li>Cosmetic reasons.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="thyroidectomy">THYROIDECTOMY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thyroidectomy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Refers to surgical removal of the thyroid gland</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indications-for-thyroidectomy">Indications for thyroidectomy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications-for-thyroidectomy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Large goiter unlikely to respond to medications</li>
<li>Neoplasm of the thyroid</li>
<li>Correction of hyperthyroidism resistant to medications</li>
<li>Patients’ choice.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="precautions-during-the-surgery">Precautions during the surgery<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#precautions-during-the-surgery" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Identification and preservation of recurrent laryngeal nerve, superior laryngeal nerve and parathyroid gland.</li>
<li>Unilateral damage to recurrent laryngeal nerve will result in post-operative hoarseness due to paralysis of one vocal cord.</li>
</ul>
<p>cont</p>
<ul>
<li>Bilateral damage to both recurrent laryngeal will result in paralysis of both vocal cords, and it may cause acute airway obstruction.</li>
<li>Damage to superior laryngeal nerve is less noticeable because mobility of vocal cords is maintained</li>
<li>Removal of parathyroid gland will result in post operative hypoparathyroidism.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pre-operative-preparation">Pre-operative preparation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pre-operative-preparation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Provide a restful, quiet environment.</li>
<li>Regulate nutritional intake, that is, food should be high in carbohydrate and protein.</li>
<li>Pre-operative investigations.</li>
<li>Prepare the patient for surgery by sharing information, giving instructions on what to expect and the informed consent</li>
</ul>
<p>cont</p>
<ul>
<li>Patient must be restored to euthyroid state.</li>
<li>Pre-operative teaching should include comfort and safety measures.</li>
<li>Coughing and deep breathing exercises should be practiced including how to support the neck manually while turning in bed because this minimises stress on the suture line after surgery and exercises of the neck</li>
</ul>
<p>cont</p>
<ul>
<li>Medications that are used to restore euthyroid state are;</li>
<li>propylthiouracil is administered until signs of hyperthyroidism have disappeared.</li>
<li>A beta-adrenergic blocking agent (propranolol) may be used to reduce the heart rate and other signs and symptoms of hyperthyroidism</li>
<li>Iodine (Lugol’s solution or potassium iodide) is administered to reduce blood loss;</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="post-operative-management">Post operative management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#post-operative-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Set Oxygen, suction equipment and a tracheostomy tray at the bed side to be readily available in case airway obstruction occurs.</li>
<li>Position patient: Semi-Fowler’s, neck on neutral position to avoid tension on the neck sutures.</li>
<li>Assess patient every two hours for 24 hours for signs of haemorrhage or tracheal compression e.g. irregular breathing, neck swelling, blood on the anterior and posterior dressing.</li>
<li>Check for signs of tetany secondary to hypoparathyroidism e.g. tingling in toes, fingers or around mouth, muscular twitching.</li>
</ol>
<p>cont</p>
<ol start="5">
<li>
<p>Monitor vital signs, temperature, pulse, respiration and blood pressure.</p>
</li>
<li>
<p>Assess frequently for frequent airway obstruction. Significant irritation of or injury to both recurrent laryngeal nerve may result to bilateral vocal cord paralysis with airway obstruction.</p>
</li>
<li>
<p>Observe for signs of thyrotoxic crisis which include tachycardia, diaphoresis, increased blood pressure and anxiety</p>
</li>
<li>
<p>Administer prescribed analgesics to control pain</p>
</li>
<li>
<p>Administer IV fluids</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications-of-thyroidectomy">Complications of thyroidectomy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-thyroidectomy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Thyrotoxicosis crisis (thyroid storm) which is an acute but rare condition in which all the hyperthyroid manifestation are worsened and may include severe tachycardia, heart failure, hyperthermia, restlessness.</li>
<li>Recurrent laryngeal nerve damage which may lead to vocal cord paralysis.</li>
<li>Difficulty in breathing due to swelling of neck tissues, haemorrhage, haematoma formation.</li>
</ul>
<p>cont</p>
<ul>
<li>Laryngeal stridor (harsh vibratory sound) may occur during respiration due to tetany from damaged or removal of parathyroid.</li>
<li>Early post-operative bleeding</li>
<li>Recurrent hyperthyroidism occurs in 1-3% within one year and then 1% per year</li>
<li>Hypothyroidism occurs in about 10% of patients within one year.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="recurrent-hyperthyroidism">Recurrent hyperthyroidism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#recurrent-hyperthyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>All three treatments (radioactive iodine therapy, antithyroid medications, and surgery) share the same complications: relapse or recurrent hyperthyroidism and permanent hypothyroidism.</li>
<li>The rate of relapse increases in patients who had very severe disease, a long history of dysfunction, ocular and cardiac symptoms, large goiter, and relapse after previous treatment.</li>
<li>The relapse rate after radioactive iodine therapy depends on the dose used in treatment.</li>
<li>Hypothyroidism occurs in almost 80% of patients at 1 year and in 90% to 100% by 5 years for both the multiple low-dose and single high-dose methods.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="parathyroid-disorders">PARATHYROID DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#parathyroid-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hypoparathyroidsm">HYPOPARATHYROIDSM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypoparathyroidsm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hypo-secretion of parathyroid hormone</li>
<li>CAUSES: tumor, removal of the gland during thyroid surgery</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathophysiology">PATHOPHYSIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Parathormone regulates calcium balance by increasing absorption of calcium from GI tract, bone resorption of calcium</li>
<li>deficiency of parathormone results in hypocalcaemia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment">ASSESSMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>if the facial nerve (immediately in front of the ear) is tapped, the client’s mouth twitches and the jaw tightens. This is called <strong>positive chvostek’s sign</strong>.</li>
<li>A positive <strong>trousseau’s sign</strong> may be elicited by placing a blood pressure cuff on the upper arm inflating it and waiting for 3 minutes.</li>
<li>The client is observed for spasm of the hand (carpopedal spasm) which is evidenced by hand flexing inward</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="presenting-features">PRESENTING FEATURES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#presenting-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Numbness and tingling sensation on the face</li>
<li>Muscle cramps</li>
<li>(+) Trousseau's and (+) Chvostek's signs</li>
<li>Bronchospams, laryngospasms, and dysphagia</li>
<li>Cardiac dysrhythmias</li>
<li>Hypotension</li>
<li>Anxiety, irritability and depression</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-interventions">NURSING INTERVENTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-interventions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Monitor VS and signs of HYPOcalcemia</li>
<li>Initiate seizure precautions and management</li>
<li>Place a tracheostomy set. O2 tank and suction at the bedside</li>
<li>Prepare CALCIUM gluconate</li>
<li>Provide a HIGH-calcium and LOW phosphate diet</li>
<li>Advise client to eat Vitamin D rich foods</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hypeparathyroidism">HYPEPARATHYROIDISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypeparathyroidism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hypersecretion of parathyroid hormones</li>
<li>The main cause is tumor.</li>
<li>It is characterized by an excessive secretion of PTH resulting in hypercalcaemia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In primary hyperparathyroidism, excessive secretion of parathyroid hormone (parathormone) results in increased urinary excretion of phosphorus and loss of calcium in the bones.</li>
<li>The bones becomes dematerialized as the calcium leaves and enters the blood stream.</li>
<li>Renal stones may develop because of an increase in serum calcium (hypercalcaemia).</li>
<li>The most common cause of primary hyperparathyroidism is an adenoma of one of the parathyroid glands</li>
</ul>
<p>cont</p>
<ul>
<li>In secondary hyperparathyroidism, the parathyroid glands secrete an excessive amount of parathormone in response to hypocalcaemia, which may be caused by vit D Deficiency, chronic renal failure, large doses of thiazide diuretics, and excessive use of laxatives and calcium supplements</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-features">Clinical features<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Symptoms due to hypercalcemia: fatigue, muscle weakness, nausea, vomiting, consitipation, cardiac dysrhythmias</li>
<li>Renal damage due to deposition of calcium phosphate. eg renal calculi, obstruction, pyelonephritis, and renal failure</li>
<li>Musculoskeletal symptoms, joint pain, pathologic fracture, deformity, and shortening of the stature</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-interventions">Nursing interventions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-interventions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>provide high fluid intake to dilute serum calcium and urine calcium levels</li>
<li>Monitor VS, Cardiac rhythm, I and O</li>
<li>Administer prescribed diuretics. i.e Furosemide to lower calcium levels. Diuretic will act on the kidney to cause fluid loss and hence lower the possibility of kidney stone formation</li>
<li>provide food low in calcium</li>
<li>Monitor for signs of renal stones, skeletal fractures. Strain all urine</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disorders-of-adrenal-medulla">DISORDERS OF ADRENAL MEDULLA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders-of-adrenal-medulla" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pheochromocytoma">PHEOCHROMOCYTOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pheochromocytoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pheochromocytoma">PHEOCHROMOCYTOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pheochromocytoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pheochromocytoma is a benign tumor of adrenal gland.</li>
<li>Originates from the chromaffin cells of the adrenal medulla.</li>
<li>Adrenal medulla Produces catecholamines: adrenaline (epinephrine) and norepinephrine</li>
<li>The tumor causes Increased secretion of epinephrine and nor-epinephrine by the adrenal medulla</li>
</ul>
<p>cont</p>
<ul>
<li>May occur at any age, but its peak incidence is between ages 40 and 50 years.</li>
<li>It affects men and women equally.</li>
<li>Because of the high incidence of pheochromocytoma in family members, the patient’s family members should be screened</li>
<li>It causes high blood pressure in 0.2% of patients with new onset of hypertension</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical Manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The typical triad of symptoms comprises headache, diaphoresis (profuse sweating) and palpitations</li>
<li>Other symptoms include :</li>
<li>Hypertension</li>
<li>Tachycardia</li>
<li>Weight loss, tremors</li>
<li>Hyperglycemia and glycosuria</li>
<li>Nausea</li>
</ul>
<p>cont</p>
<ul>
<li>Vomiting</li>
<li>Abdominal pain</li>
<li>Vertigo</li>
<li>blurring of vision</li>
<li>Tinnitus</li>
<li>dyspnea.</li>
<li>Postural hypotension occurs in 70% of patients with untreated pheochromocytoma</li>
</ul>
<p>Assessment and Diagnostic Findings</p>
<ul>
<li>Pheochromocytoma is suspected if signs of sympathetic nervous system overactivity occur in association with marked elevation of blood pressure.</li>
<li>These signs can be associated with the “five Hs”: hypertension, headache, hyperhidrosis (excessive sweating), hypermetabolism, and hyperglycemia.</li>
</ul>
<p>cont</p>
<ul>
<li>Measurements of urine and plasma levels of catecholamines are the most direct and conclusive tests for overactivity of the adrenal medulla</li>
<li>Measurements of urinary catecholamine metabolites (metanephrines [MN] and vanillylmandelic acid [VMA]) or free catecholamines are the standard diagnostic tests used in the diagnosis of pheochromocytoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Alpha adrenergic blocking agents (eg, phentolamin [Regitine]) or smooth muscle relaxants (eg, sodium nitroprusside [Nipride]) to lower the blood pressure quickly.</li>
<li>Beta-adrenergic blocking agents, such as propranolol (Inderal), may be used in patients with cardiac dysrhythmias or those not responsive to alpha-blockers</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="surgical-management">Surgical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#surgical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The definitive treatment of pheochromocytoma is surgical removal of the tumor, usually with adrenalectomy (surgical removal of adrenal gland)</li>
<li>Bilateral adrenalectomy may be necessary if tumors are present in both adrenal glands.</li>
<li>Patient preparation includes control of blood pressure and blood volumes; usually this is carried out over 7 to 10 days</li>
<li>Phentolamine or phenoxybenzamine (Dibenzyline) may be used safely without causing undue hypotension</li>
</ul>
<p>cont</p>
<ul>
<li>Hydration before, during, and after surgery to prevent hypotension.</li>
<li>Manipulation of the tumor during surgical excision may cause release of stored epinephrine and norepinephrine, with marked increases in blood pressure and changes in heart rate.</li>
<li>use of sodium nitroprusside (Nipride) and alpha-adrenergic blocking agents may be required during and after surgery to control increases in catecholamine levels</li>
</ul>
<p>cont</p>
<ul>
<li>Corticosteroid replacement is required if bilateral adrenalectomy has been necessary</li>
<li>Corticosteroids may also be necessary for the first few days or weeks after removal of a single adrenal gland</li>
<li>Intravenous administration of corticosteroids (methylprednisolone sodium succinate [Solu-Medrol]) may begin the evening before surgery and continue during the early postoperative period to prevent adrenal insufficiency</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management">Nursing management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Monitor VS especially BP and document the vitals</li>
<li>Monitor for HYPERTENSIVE crisis: it is a severe increase in blood pressure that can lead to stroke and impairment of an organ</li>
<li>Avoid palpating the gland as it stimulates the tumor that can cause increased BP</li>
<li>Administer Anti-hypertensive agents like alpha-adrenergic blockers Phenoxybenzamine</li>
<li>Monitor blood glucose and urine glucose</li>
</ol>
<p>cont</p>
<ol start="5">
<li>Promote adequate rest and sleep periods</li>
<li>provide HIGH calorie foods and Vitamins/mineral supplements</li>
<li>Prepare patient for possible surgery</li>
</ol>
<p><strong>Post-operative management</strong></p>
<ul>
<li>Monitor vitals signs every 15 minutes until the patient is stable</li>
<li>Administer prescribed corticosteroid to prevent adrenal insufficiency.</li>
</ul>
<p>cont</p>
<ul>
<li>Blood sugars and ECG monitoring until the patient is stable</li>
<li>Intravenous fluids, normal saline alternated with 10% dextrose to prevent hypotension</li>
<li>Monitor the drainage to check for the constant changes in drains. The discharge must be clear red and reducing daily</li>
<li>Provide the patient with a well balanced diet.</li>
<li>On discharge give health education on self monitoring of BP and regular check ups.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disorders-of-adrenal-cortex">DISORDERS OF ADRENAL CORTEX<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders-of-adrenal-cortex" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>ADDISON'S DISEASE</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="addison-s-disease">ADDISON'S DISEASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#addison-s-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Refers to adrenal insufficiency resulting from decreased secretion of adrenal cortex hormones, especially glucocorticoids and mineralocorticoids</li>
<li>Hypofunction of adrenal cortex</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Autoimmune destruction of the gland</li>
<li>Atrophy of the adrenal gland</li>
<li>surgical removal of both adrenal glands</li>
<li>Infections like Tuberculosis and histoplasmosis</li>
<li>Inadequate secretion of ACTH from the pituitary gland</li>
<li>Therapeutic use of corticosteroids</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inadequate secretion of ACTH, autoimmune destruction of the gland or infections of the gland leads to decreased secretion of glucocorticoids and mineralocorticoids.</li>
<li>This results in hypoglycemia, weight loss, hyponatremia, hyperkalemia, hypovolemia and hypotension.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-e44dbe41.jpeg" alt="img-54.jpeg"></p>
<ul>
<li>Damage to the adrenal cortex; progressive atrophy of gland.</li>
<li>Deficiency in cortisone and aldosterone</li>
<li>Imbalance of these hormones causes deregulation of important body functions that are potentially life-threatening.</li>
<li>Disease manifests itself when 90% of the adrenal gland is destroyed.</li>
<li>80% of cases have an autoimmune origin, 20% result from infection.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Weight loss</li>
<li>GI disturbances</li>
<li>Muscle weakness, lethargy and fatigue</li>
<li>Hyponatremia</li>
<li>Hyperkalemia</li>
<li>Hypoglycemia</li>
<li>dehydration and hypovolemia</li>
<li>Increased skin pigmentation (bronze pigmentation) due to high levels of circulating ACTH</li>
</ol>
<p>ADDISON'S DISEASE</p>
<p>BRONZE
PIGMENTATION
OF SKIN
CHANGES IN
DISTRIBUTION
OF BODY HAIR
GI DISTURBANCES
WEAKNESS</p>
<p>HYPOGLYCEMIA
POSTURAL
HYPOTENSION
WEIGHT LOSS</p>
<p>ADRENAL CRISIS:
PROFOUND FATIGUE
DEHYDRATION
VASCULAR COLLAPSE
RENAL SHUT DOWN
↓ SERUM NA
↑ SERUM K</p>
<p>©1994 Nursing Education Consultants
JMKLER</p>
<p><img src="assets/images/image-20251224-965e40ca.jpeg" alt="img-55.jpeg">
Fig. 2 Addison's disease - hyperpigmentation involving the palms of the hand.</p>
<p>Assessment and Diagnostic Findings</p>
<ul>
<li>The diagnosis is confirmed by laboratory test results.</li>
</ul>
<p>Laboratory findings include :</p>
<ul>
<li>low levels of adrenocortical hormones in the blood or urine and decreased serum cortisol levels</li>
<li>Decreased blood glucose (hypoglycemia) and sodium (hyponatremia) levels, an increased serum potassium (hyperkalemia) level and an increased white blood cell count (leukocytosis).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hydrocortisone is administered intravenously, followed with 5% to replace the cortisol hormones.</li>
<li>Vasopressor amines (epineprine) may be required if hypotension persists.</li>
<li>Hormonal replacement of aldosterone if necessary</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management">Nursing management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Monitor the patient for signs and symptoms indicative of <strong>addisonian crisis</strong>. These symptoms are often the manifestations of shock:
<strong>hypotension; rapid, weak pulse; rapid respiratory rate; pallor; and extreme weakness</strong></p>
</li>
<li>
<p>Administer prescribed hormonal hydrocortisone to replace adrenal insufficiency</p>
</li>
</ol>
<p>cont</p>
<ol start="3">
<li>Monitor VS especially BP and document them</li>
<li>Monitor weight and I and O and document in the input output chart</li>
<li>Monitor blood glucose level and K+ levels to rule out hypoglycemia</li>
<li>Provide a high-protein, high carbohydrate and increased sodium intake</li>
<li>Avoid physical and psychological Stressors. These include exposure to cold, infection, and emotional distress</li>
</ol>
<p>cont</p>
<ol start="9">
<li>
<p>Educate the client regarding lifelong treatment, avoidance of strenuous activities, stress and seeking prompt consultation during illness</p>
</li>
<li>
<p>Initiate and maintain iv infusion of normal saline.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="addisonian-crisis">ADDISONIAN CRISIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#addisonian-crisis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A life-threatening disorder caused by acute severe adrenal insufficiency</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="precipitating-factors">PRECIPITATING FACTORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#precipitating-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Infection</li>
<li>Trauma</li>
<li>Severe stress</li>
<li>Dehydration</li>
<li>Exposure to cold</li>
<li>surgery</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="presenting-features">Presenting features<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#presenting-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is characterized by cyanosis and the classic signs of circulatory shock: pallor, apprehension, rapid and weak pulse, rapid respirations and low blood pressure.</li>
<li>In addition, the patient may complain of headache, nausea, abdominal pain, and diarrhea and show signs of confusion and restlessness</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hydrocortisone (Solu-Cortef) is administered intravenously, followed with 5% dextrose in normal saline</li>
<li>Vasopressor amines may be required if hypotension persists.</li>
<li>Antibiotics may be administered if infection has precipitated adrenal crisis in a patient with chronic adrenal insufficiency</li>
<li>lifelong replacement of corticosteroids and mineralocorticoids to prevent recurrence of adrenal insufficiency if adrenal gland does not recover.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-interventions">Nursing interventions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-interventions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Avoid physical and psychological stressors must be avoided. These include exposure to cold, overexertion, infection, and emotional distress</li>
<li>Administer IV Glucocorticoids, usually hydrocortisone and other prescribed medications</li>
<li>Monitor VS frequently, Monitor I and O, neurological status, electrolyte imbalances and blood glucose</li>
</ol>
<p>cont</p>
<ol start="4">
<li>Administer IV Fluids : normal saline and 5% dextrose</li>
<li>Maintain bed rest to conserve energy</li>
<li>Health education on lifelong hormone replacement therapy.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cushing-s-syndrome">CUSHING'S SYNDROME<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cushing-s-syndrome" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A condition resulting from the hyper-secretion of Glucocorticoids from the adrenal cortex</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">CAUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Excessive use of corticosteroids</li>
<li>Tumor of the pituitary gland that produces ACTH and stimulates the adrenal cortex to increase its hormone secretion despite adequate amounts being produced</li>
<li>Primary hyperplasia of the adrenal gland.</li>
<li>Malignancies that produce ACTH</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathophysiology">Pathophysiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathophysiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Cushing syndrome is caused by mechanism such as tumor of pituitary that produces ACTH that stimulates adrenal cortex to increase production of Glucocorticoids and androgens</li>
<li>When overproduction of the adrenal cortical hormone occurs, arrest of growth, obesity, and musculoskeletal changes occur along with glucose intolerance</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-manifestations">Clinical manifestations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Generalized muscle weakness and wasting because of excess protein catabolism</li>
<li>central obesity (truncal obesity)</li>
<li>Moon-face, due to fat deposit on the areas</li>
<li>Buffalo hump due to fat deposition</li>
<li>Easy bruisability due to thinned skin esp on the lower limb (along the tibia) that are slow to heal</li>
<li>Reddish-purplish striae on the abdomen, breast and thighs</li>
</ol>
<p>cont</p>
<ol start="7">
<li>Hypertension because of Na+ and H2o Retention</li>
<li>Hyperglycemia</li>
<li>Osteoporosis</li>
<li>Amenorrhea or oligomenorrea</li>
<li>There is increased susceptibility to infection</li>
<li>There is an excessive growth of hair on the face (hirsutism) in women and other parts of the body</li>
<li>Irritability and depression</li>
<li>In male, there is gynaecomastia, erectile dysfunction and decreased sexual interest</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cushing-s-syndrome">CUSHING'S SYNDROME<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cushing-s-syndrome" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-0d86ae58.jpeg" alt="img-56.jpeg"></p>
<table><thead><tr><th><img src="assets/images/image-20251224-1483e917.jpeg" alt="img-57.jpeg"></th></tr></thead></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id=""><img src="assets/images/image-20251224-fb001227.jpeg" alt="img-58.jpeg"><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h2></div>
<table><thead><tr><th></th><th></th><th></th></tr></thead></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="normal">Normal<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#normal" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cushing-s">Cushing's<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cushing-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251224-ef4ccd2e.jpeg" alt="img-59.jpeg"></p>
<p><img src="assets/images/image-20251224-14f034f5.jpeg" alt="img-60.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment-and-diagnostic-findings">Assessment and Diagnostic Findings<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-and-diagnostic-findings" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Indicators of Cushing’s syndrome include:</li>
</ul>
<ol>
<li>An increase in serum sodium and blood glucose levels</li>
<li>Decreased serum concentration of potassium,</li>
<li>Reduction in the number of blood eosinophils, and disappearance of lymphoid tissue</li>
<li>An overnight <strong>dexamethasone suppression test</strong> is the most used screening test for diagnosis of pituitary and adrenal causes of Cushing’s syndrome</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-management">Medical Management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Surgery if the cause is tumor of the pituitary gland. Surgical removal of the tumor by trans-sphenoidal hypophysectomy is the treatment of choice and has a 90% success rate</li>
<li>Radiation of the pituitary gland</li>
<li>Adrenal ezyme inhibitors eg metyrapone, ketoconazole</li>
<li>Adrenalectomy is the treatment of choice in patients with primary adrenal hypertrophy</li>
<li>Tapering of corticosteroids if it was cause the problem</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-management">Nursing management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Monitor I and O, weight and VS</li>
<li>Monitor laboratory values- glucose, Na, K and Ca2+</li>
<li>Provide meticulous skin care. Avoid USE OF ADHESIVE TAPE!!</li>
<li>Promote a relaxing, quiet environment for rest and sleep.</li>
<li>Provide a LOW carbohydrate, LOW sodium and HIGH protein diet</li>
</ol>
<p>cont</p>
<ul>
<li>Protect the patient from infection by ensuring aseptic procedures. Avoid unnecessary exposure to others with infections</li>
<li>Health education on identification of signs of cortical sufficiency</li>
</ul>
<p>Hyperadrenalisms</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="primary-hyperaldosteronism">Primary Hyperaldosteronism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#primary-hyperaldosteronism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Primary hyperaldosteronism – excess aldosterone secretion which is independent of the renin-angiotensin system (Conn’s syndrome)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Aldosterone secreting adenoma</li>
<li>Bilateral hyperplasia of the cortex</li>
<li>Rarely carcinoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-features">Clinical features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Hypertension, hypokalemia, sodium retention, muscle weakness, paraesthesia, ECG changes, cardiac decompensation</p>
</li>
<li>
<p>Aldosterone, by inducing renal distal tubular reabsorption of sodium, enhances secretion of potassium and hydrogen ions, causing hypernatremia, hypokalemia, and metabolic alkalosis.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mortality-morbidity">Mortality/Morbidity:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mortality-morbidity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The morbidity and mortality associated with Conn syndrome, are primarily related to;</li>
</ul>
<p>1- Hypertension, especially if left untreated for many years, can lead to many complications, including heart disease (eg, coronary artery disease, congestive heart failure), stroke, and intracerebral hemorrhage (with very high blood pressure)</p>
<p>2-Hypokalemia, especially if severe, causes cardiac arrhythmias, which can be fatal</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-2ry-hyperaldosteronism">II- 2ry hyperaldosteronism:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-2ry-hyperaldosteronism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>There is increased renin-angiotensin with increased aldosterone secretion;</li>
<li>CHF (congestive heart failure)</li>
<li>Liver cirrhosis and ascites</li>
<li>Nephrotic syndrome</li>
<li>Renal artery stenosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-features">Clinical features<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Clinical suspicions should be raised when</p>
<ul>
<li>Hypertension occur with hypokalemia.</li>
<li>Moderate to severe hypertension</li>
<li>Hypokalemia</li>
<li>Muscle weakness</li>
<li>Malaise</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="investigations">Investigations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#investigations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Blood : Hypokalemia
Plasma aldosterone</li>
<li>Urine : Increase urinary potassium</li>
<li>Imaging : US
CT
MRI</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="treatment">Treatment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Pharmacotherapy and surgery</p>
</li>
<li>
<p>Spironolactone</p>
</li>
<li>
<p>Adrenalectomy</p>
</li>
<li>
<p>Nursing diagnosis for the above patient???</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="references">References<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#references" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sussanne, C (2010). Brunner and Saddarth's text book of medical surgical nursing. New York, NY: Wolters Kluwer Health.</li>
<li>Katzung, G (2007). Basic and clinical pharmacology.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="xiexie-da-jia">XieXie da jia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#xiexie-da-jia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>